UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark one)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March ~~28, 2020~~27, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-50307

FormFactor, Inc.

(Exact name of registrant as specified in its charter)


Delaware						13-3711155
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

7005 Southfront Road, Livermore, California 94551

(Address of principal executive offices, including zip code)

(925) 290-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.001 par value

FORM

Nasdaq Global Market

______________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of the Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-accelerated Filer

☐

Smaller Reporting Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~May 4, 2020, 76,161,842~~April 30, 2021, 77,622,717 shares of the registrant’s common stock, par value $0.001 per share, were outstanding.

FORMFACTOR, INC.

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH ~~28, 2020~~27, 2021

INDEX


Part I.	Financial Information

Item 1.	Financial Statements (Unaudited):

	Condensed Consolidated Balance Sheets as of March ~~28, 20~~2 207 , 202 1 and December 2 86 , ~~201~~20 92 0	3

	Condensed Consolidated Statements of Income for the three months ended ~~ended~~March 2 7 , 202 1 and March 28, 20 20 ~~and~~ ~~March~~30 ~~, 201~~9	4

	Condensed Consolidated Statements of Comprehensive Income for the three months ended March ~~28, 20~~2 207 , 202 1 and March 2 308 , ~~201~~20 920	5

	Condensed Consolidated Statement of Stockholders' Equity for the three months ended March ~~28, 20~~2 207 , 202 1 and March 28, 20 30 ~~, 201~~920	6

	Condensed Consolidated Statements of Cash Flows for the three months ended March ~~28, 20~~2 207 , 202 1 and March 28, 20 30 ~~, 201~~920	7

	Notes to Condensed Consolidated Financial Statements	89

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2024

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3032

Item 4.	Controls and Procedures	3033

Part II.	Other Information	3033



Item 1A.	Risk Factors	3033

Item 2.	Unregistered Sales of Equity Securities and use of proceeds	34







Item 6.	Exhibits	3235

Signatures		3336

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

FORMFACTOR, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


		March 28, 2020		December 28, 2019			March 27, 2021		December 26, 2020
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	169,607	$	144,545	Cash and cash equivalents	$	173,616	$	187,225
Marketable securities	Marketable securities	69,759		76,327		Marketable securities	94,093		67,810
Accounts receivable, net of allowance for doubtful accounts of $222 and $222		90,100		97,868
Accounts receivable, net of allowance for doubtful accounts of $232 and $248						Accounts receivable, net of allowance for doubtful accounts of $232 and $248	103,500		107,603
Inventories, net	Inventories, net	78,983		83,258		Inventories, net	104,727		99,229
Restricted cash	Restricted cash	2,107		1,981		Restricted cash	2,798		1,904

Prepaid expenses and other current assets	Prepaid expenses and other current assets	15,699		15,064		Prepaid expenses and other current assets	19,371		23,303
Total current assets	Total current assets	426,255		419,043		Total current assets	498,105		487,074
Restricted cash	Restricted cash	1,361		1,411		Restricted cash	1,894		1,969
Operating lease, right-of-use-assets	Operating lease, right-of-use-assets	36,212		31,420		Operating lease, right-of-use-assets	37,208		30,756
Property, plant and equipment, net of accumulated depreciation of $277,017 and $273,001		63,745		58,747
Property, plant and equipment, net of accumulated depreciation						Property, plant and equipment, net of accumulated depreciation	112,312		104,103
Goodwill	Goodwill	200,378		199,196		Goodwill	214,218		212,761
Intangibles, net	Intangibles, net	50,139		57,610		Intangibles, net	48,786		59,147
Deferred tax assets	Deferred tax assets	70,273		71,252		Deferred tax assets	65,821		66,242
Other assets	Other assets	1,016		1,203		Other assets	1,867		1,165
Total assets	Total assets	$	849,379	$	839,882	Total assets	$	980,211	$	963,217

LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY					LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	40,139	$	40,914	Accounts payable	$	67,720	$	62,045
Accrued liabilities	Accrued liabilities	29,175		36,439		Accrued liabilities	43,468		55,342
Current portion of term loans, net of unamortized issuance costs	Current portion of term loans, net of unamortized issuance costs	31,535		42,846		Current portion of term loans, net of unamortized issuance costs	9,260		9,516

Deferred revenue	Deferred revenue	9,830		9,810		Deferred revenue	18,644		20,964
Operating lease liabilities	Operating lease liabilities	6,815		6,551		Operating lease liabilities	7,557		6,704
Total current liabilities	Total current liabilities	117,494		136,560		Total current liabilities	146,649		154,571
Term loan, less current portion, net of unamortized issuance costs		13,642		15,639

Term loans, less current portion, net of unamortized issuance costs						Term loans, less current portion, net of unamortized issuance costs	22,390		24,978
Deferred tax liabilities	Deferred tax liabilities	6,095		6,986		Deferred tax liabilities	4,965		5,346
Long-term operating lease liabilities	Long-term operating lease liabilities	34,028		29,088		Long-term operating lease liabilities	33,485		27,996
Other liabilities	Other liabilities	11,703		10,612		Other liabilities	6,189		6,242
Total liabilities	Total liabilities	182,962		198,885		Total liabilities	213,678		219,133

Stockholders’ equity:	Stockholders’ equity:					Stockholders’ equity:
Preferred stock, $0.001 par value:
10,000,000 shares authorized; no shares issued and outstanding		—		—

Common stock, $0.001 par value:	Common stock, $0.001 par value:					Common stock, $0.001 par value:
250,000,000 shares authorized; 76,158,251 and 75,764,990 shares issued and outstanding		77		76
250,000,000 shares authorized; 77,758,530 and 77,437,997 shares issued and outstanding						250,000,000 shares authorized; 77,758,530 and 77,437,997 shares issued and outstanding	78		78
Treasury stock, at cost, 136,402 and 0 shares						Treasury stock, at cost, 136,402 and 0 shares	(5,738)		0
Additional paid-in capital	Additional paid-in capital	895,600		885,821		Additional paid-in capital	915,136		903,838
Accumulated other comprehensive loss		(909)		(659)
Accumulated other comprehensive income						Accumulated other comprehensive income	3,150		5,886
Accumulated deficit	Accumulated deficit	(228,351)		(244,241)		Accumulated deficit	(146,093)		(165,718)
Total stockholders’ equity	Total stockholders’ equity	666,417		640,997		Total stockholders’ equity	766,533		744,084
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	849,379	$	839,882	Total liabilities and stockholders’ equity	$	980,211	$	963,217

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts)

(Unaudited)


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Revenues	Revenues	$	160,753	$	132,213	Revenues	$	186,636	$	160,753
Cost of revenues	Cost of revenues	93,363		79,692		Cost of revenues	109,930		93,363
Gross profit	Gross profit	67,390		52,521		Gross profit	76,706		67,390
Operating expenses:	Operating expenses:					Operating expenses:
Research and development	Research and development	21,267		19,723		Research and development	24,046		21,267
Selling, general and administrative	Selling, general and administrative	27,693		25,184		Selling, general and administrative	30,015		27,693
Total operating expenses	Total operating expenses	48,960		44,907		Total operating expenses	54,061		48,960
Operating income	Operating income	18,430		7,614		Operating income	22,645		18,430
Interest income	Interest income	685		580		Interest income	194		685
Interest expense	Interest expense	(318)		(595)		Interest expense	(180)		(318)
Other expense, net		(91)		(84)
Other income (expense), net						Other income (expense), net	172		(91)
Income before income taxes	Income before income taxes	18,706		7,515		Income before income taxes	22,831		18,706
Provision for income taxes	Provision for income taxes	2,816		2,032		Provision for income taxes	3,206		2,816
Net income	Net income	$	15,890	$	5,483	Net income	$	19,625	$	15,890
Net income per share:	Net income per share:					Net income per share:
Basic	Basic	$	0.21	$	0.07	Basic	$	0.25	$	0.21
Diluted	Diluted	$	0.20	$	0.07	Diluted	$	0.25	$	0.20
Weighted-average number of shares used in per share calculations:	Weighted-average number of shares used in per share calculations:					Weighted-average number of shares used in per share calculations:
Basic	Basic	76,005		74,362		Basic	77,598		76,005
Diluted	Diluted	78,510		76,009		Diluted	79,988		78,510

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Net income	Net income	$	15,890	$	5,483	Net income	$	19,625	$	15,890
Other comprehensive loss, net of tax:	Other comprehensive loss, net of tax:					Other comprehensive loss, net of tax:
Translation adjustments and other	Translation adjustments and other	(399)		(917)		Translation adjustments and other	(2,379)		(399)
Unrealized gains (losses) on available-for-sale marketable securities		(27)		151
Unrealized losses on available-for-sale marketable securities						Unrealized losses on available-for-sale marketable securities	(131)		(27)
Unrealized gains (losses) on derivative instruments	Unrealized gains (losses) on derivative instruments	176		(613)		Unrealized gains (losses) on derivative instruments	(226)		176
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	(250)		(1,379)		Other comprehensive loss, net of tax	(2,736)		(250)
Comprehensive income	Comprehensive income	$	15,640	$	4,104	Comprehensive income	$	16,889	$	15,640

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except shares)

(Unaudited)


		Shares	Common Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Total			Shares of Common Stock	Common Stock		Shares of Treasury Stock	Treasury Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total
		Three Months Ended March 28, 2020																				Three Months Ended March 27, 2021
Balances, December 28, 2019		75,764,990	$	76	$	885,821	$	(659)	$	(244,241)	$	640,997
Balances, December 26, 2020													Balances, December 26, 2020	77,437,997	$	78	0	$	0	$	903,838	$	5,886	$	(165,718)	$	744,084
Issuance of common stock under the Employee Stock Purchase Plan	Issuance of common stock under the Employee Stock Purchase Plan	311,591	—		4,066		—		—		4,066		Issuance of common stock under the Employee Stock Purchase Plan	228,784	—		—	—		5,065		—		—		5,065
Issuance of common stock pursuant to exercise of options	Issuance of common stock pursuant to exercise of options	55,769	1		446		—		—		447		Issuance of common stock pursuant to exercise of options	50,000	0		—	—		422		—		—		422
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	25,901	—		(385)		—		—		(385)		Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	41,749	0		—	—		(1,141)		—		—		(1,141)

Purchase of common stock through repurchase program													Purchase of common stock through repurchase program	—	—		(136,402)	(5,738)		—		—		—		(5,738)
Stock-based compensation	Stock-based compensation	—	—		5,652		—		—		5,652		Stock-based compensation	—	—		—	—		6,952		—		—		6,952
Other comprehensive loss	Other comprehensive loss	—	—		—		(250)		—		(250)		Other comprehensive loss	—	—		—	—		—		(2,736)		—		(2,736)
Net income	Net income	—	—		—		—		15,890		15,890		Net income	—	—		—	—		—		—		19,625		19,625
Balances, March 28, 2020		76,158,251	$	77	$	895,600	$	(909)	$	(228,351)	$	666,417
Balances, March 27, 2021													Balances, March 27, 2021	77,758,530	$	78	(136,402)	$	(5,738)	$	915,136	$	3,150	$	(146,093)	$	766,533

Shares Common Stock Additional Paid-in Capital Accumulated Other Comprehensive Loss Accumulated Deficit Total
Three Months Ended March 30, 2019
Balances, December 29, 2018 74,139,712 $ 74 $ 862,897 $ 780 $ (283,587) $ 580,164
Issuance of common stock under the Employee Stock Purchase Plan 301,497 — 3,670 — — 3,670
Issuance of common stock pursuant to exercise of options for cash 19,207 — 90 — — 90
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 28,082 — (302) — — (302)
Stock-based compensation — — 5,262 — — 5,262
Other comprehensive loss — — — (1,379) — (1,379)
Net income — — — — 5,483 5,483
Balances, March 30, 2019 74,488,498 $ 74 $ 871,617 $ (599) $ (278,104) $ 592,988


	Shares of Common Stock	Common Stock		Shares of Treasury Stock	Treasury Stock		Additional Paid-in Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Total
	Three Months Ended March 28, 2020
Balances, December 28, 2019	75,764,990	$	76	0	$	0	$	885,821	$	(659)	$	(244,241)	$	640,997
Issuance of common stock under the Employee Stock Purchase Plan	311,591	—		—	—		4,066		—		—		4,066
Issuance of common stock pursuant to exercise of options	55,769	1		—	—		446		—		—		447
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax	25,901	0		—	—		(385)		—		—		(385)

Stock-based compensation	—	—		—	—		5,652		—		—		5,652
Other comprehensive loss	—	—		—	—		—		(250)		—		(250)
Net income	—	—		—	—		—		—		15,890		15,890
Balances, March 28, 2020	76,158,251	$	77	0	0		$	895,600	$	(909)	$	(228,351)	$	666,417

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income	Net income	$	15,890	$	5,483	Net income	$	19,625	$	15,890
Adjustments to reconcile net income to net cash provided by operating activities:	Adjustments to reconcile net income to net cash provided by operating activities:					Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	Depreciation	4,561		3,947		Depreciation	6,130		4,561
Amortization	Amortization	7,263		7,090		Amortization	6,805		7,263
Accretion of discount on investments		(28)		(71)

Reduction in the carrying amount of right-of-use assets	Reduction in the carrying amount of right-of-use assets	1,511		1,277		Reduction in the carrying amount of right-of-use assets	1,811		1,511

Stock-based compensation expense	Stock-based compensation expense	5,623		5,295		Stock-based compensation expense	7,077		5,623
Amortization of debt issuance costs		19		51
Deferred income tax benefit		(198)		—

Provision for excess and obsolete inventories	Provision for excess and obsolete inventories	3,287		2,725		Provision for excess and obsolete inventories	3,394		3,287
Loss on disposal of long-lived assets		204		118

Loss on derivative instruments		676		59
Foreign currency transaction (losses) gains		(266)		121

Other adjustments to reconcile net income to net cash provided by operating activities						Other adjustments to reconcile net income to net cash provided by operating activities	2,140		407
Changes in assets and liabilities:	Changes in assets and liabilities:					Changes in assets and liabilities:
Accounts receivable	Accounts receivable	7,803		13,805		Accounts receivable	3,576		7,803
Inventories	Inventories	928		(8,658)		Inventories	(9,911)		928
Prepaid expenses and other current assets	Prepaid expenses and other current assets	(240)		2,167		Prepaid expenses and other current assets	3,011		(240)

Other assets	Other assets	194		(564)		Other assets	(50)		194
Accounts payable	Accounts payable	763		(7,148)		Accounts payable	5,722		763
Accrued liabilities	Accrued liabilities	(6,970)		(6,275)		Accrued liabilities	(12,732)		(6,970)

Other liabilities	Other liabilities	33		32		Other liabilities	114		33
Deferred revenues	Deferred revenues	(123)		1,931		Deferred revenues	(2,411)		(123)
Operating lease liabilities	Operating lease liabilities	(1,591)		(1,690)		Operating lease liabilities	(1,945)		(1,591)

Net cash provided by operating activities	Net cash provided by operating activities	39,339		20,638		Net cash provided by operating activities	32,356		39,339
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Acquisition of property, plant and equipment	Acquisition of property, plant and equipment	(12,050)		(6,028)		Acquisition of property, plant and equipment	(13,470)		(12,050)

Proceeds from sale of a subsidiary	Proceeds from sale of a subsidiary	40		28		Proceeds from sale of a subsidiary	0		40

Purchases of marketable securities	Purchases of marketable securities	(16,441)		(12,382)		Purchases of marketable securities	(41,062)		(16,441)
Proceeds from maturities and sales of marketable securities	Proceeds from maturities and sales of marketable securities	23,009		9,050		Proceeds from maturities and sales of marketable securities	14,610		23,009

Net cash used in investing activities	Net cash used in investing activities	(5,442)		(9,332)		Net cash used in investing activities	(39,922)		(5,442)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from issuances of common stock	Proceeds from issuances of common stock	4,513		3,870		Proceeds from issuances of common stock	5,487		4,513

Purchase of common stock through stock repurchase program						Purchase of common stock through stock repurchase program	(5,738)		0
Tax withholdings related to net share settlements of equity awards	Tax withholdings related to net share settlements of equity awards	(385)		(302)		Tax withholdings related to net share settlements of equity awards	(1,141)		(385)

Principal repayments on term loans	Principal repayments on term loans	(13,199)		(7,500)		Principal repayments on term loans	(2,376)		(13,199)

Net cash used in financing activities	Net cash used in financing activities	(9,071)		(3,932)		Net cash used in financing activities	(3,768)		(9,071)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	312		(207)		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,456)		312
Net increase in cash, cash equivalents and restricted cash		25,138		7,167
Net increase (decrease) in cash, cash equivalents and restricted cash						Net increase (decrease) in cash, cash equivalents and restricted cash	(12,790)		25,138
Cash, cash equivalents and restricted cash, beginning of period	Cash, cash equivalents and restricted cash, beginning of period	147,937		100,546		Cash, cash equivalents and restricted cash, beginning of period	191,098		147,937
Cash, cash equivalents and restricted cash, end of period	Cash, cash equivalents and restricted cash, end of period	$	173,075	$	107,713	Cash, cash equivalents and restricted cash, end of period	$	178,308	$	173,075
Non-cash investing and financing activities:

Change in accounts payable and accrued liabilities related to property, plant and equipment purchases		$	2,116	$	(1,253)
Operating lease, right-of-use assets obtained in exchange for lease obligations		6,307		35,713
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net		$	2,419	$	1,082
Cash paid for interest		291		302

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Three Months Ended
	March 27, 2021		March 28, 2020
Non-cash investing and financing activities:



Change in accounts payable and accrued liabilities related to property, plant and equipment purchases	$	1,087	$	(2,116)
Operating lease, right-of-use assets obtained in exchange for lease obligations	8,572		6,307

Supplemental disclosure of cash flow information:
Cash paid for income taxes, net	$	1,034	$	2,419
Cash paid for interest	173		291

Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	$	173,616	$	169,607
Restricted cash, current	2,798		2,107
Restricted cash	1,894		1,361
Total cash, cash equivalents and restricted cash	$	178,308	$	173,075

The accompanying notes are an integral part of these condensed consolidated financial statements.

FORMFACTOR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 — Basis of Presentation and New Accounting Pronouncements

Basis of Presentation

The accompanying condensed consolidated financial information of FormFactor, Inc. is unaudited and has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission ~~("SEC"~~(“SEC”). However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The ~~financial information as of December 28, 2019 is derived from our 2019 Annual Report on Form 10-K. The~~ condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our ~~2019~~2020 Annual Report on Form 10-K filed with the SEC on February ~~21, 2020.~~22, 2021. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.

Fiscal Year

We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal ~~2020~~2021 and ~~2019~~2020 each contain 52 weeks and the three months ended March ~~28, 2020~~27, 2021 and March ~~30, 2019~~28, 2020 each contained 13 weeks. Fiscal ~~2020~~2021 will end on December ~~26, 2020.~~25, 2021.

~~Critical~~Significant Accounting Policies

Our ~~critical~~significant accounting policies have not changed during the three months ended March ~~28, 2020~~27, 2021 from those disclosed in our Annual Report on Form 10-K for the year ended December ~~28, 2019.~~26, 2020.

Reclassifications

Certain immaterial reclassifications were made to the prior year financial statements to conform to the current year presentation.

New Accounting Pronouncements

ASU ~~2016-13~~2019-12

In ~~June 2016,~~December 2019, the Financial Accounting Standard Board ~~("FASB"~~(“FASB”) issued Accounting Standards Update ~~("ASU"~~(“ASU”) No. 2016-13, "Measurement of Credit Losses on Financial Instruments (Topic 326)." The provisions of this standard require financial assets measured at amortized cost to be presented at the net amount expected to be collected. An allowance account would be established to present the net carrying value at the amount expected to be collected. ASU 2016-13 also provides that credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. The guidance was amended through various ASU's subsequent to ASU 2016-13, all of which was effective for us beginning fiscal 2020. We adopted ASU 2016-13 on a prospective basis on December 29, 2019, the first day of fiscal 2020. The adoption did not have a material effect on our financial position, results of operations or cash flows.

~~ASU 2018-15~~

In August 2018, the FASB issued ASU 2018-15, "Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract." The new guidance clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2019. We adopted ASU 2018-15 on a prospective basis on December 29, 2019, the first day of fiscal 2020. The adoption did not have a material effect on our financial position, results of operations or cash flows.

~~ASU 2019-12~~

~~In December 2019, the FASB issued ASU~~ 2019-12, “Income Taxes (Topic 740),” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. ~~Early~~We adopted ASU 2019-12 on a prospective basis on December 27, 2020, the first day of fiscal 2021. The adoption ~~of the amendments is permitted, including adoption in any interim period for which financial statements~~did not have ~~not yet been issued. Depending~~a material effect on ~~the amendment, adoption may be applied on the retrospective, modified retrospective or prospective basis. We have not yet determined the impact of this standard on~~ our consolidated financial position, results of operations or cash flows.

ASU 2020-04

In March 2020, the FASB issued ASU 2020-04, “Referenced Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company has not yet applied the relief afforded by these standard amendments and is currently assessing contracts that will require modification due to reference rate reform to which these standard amendments may be applied.

Note 2 — Concentration of Credit and Other Risks

Each of the following customers accounted for 10% or more of our revenues for the periods indicated:


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Intel Corporation	Intel Corporation	36.2	%	21.3	%	Intel Corporation	28.1	%	36.2	%
Taiwan Semiconductor Manufacturing Co., LTD.						Taiwan Semiconductor Manufacturing Co., LTD.	11.5	%	*

Samsung Electronics., LTD.		*		13.8

		36.2	%	35.1	%		39.6	%	36.2	%

*Represents less than 10% of total revenues.

At March ~~28,~~27, 2021, one customer accounted for 22.8% of gross accounts receivable. At December 26, 2020, two customers accounted for ~~27.7%~~15.3% and ~~15.3% of gross accounts receivable, respectively. At December 28, 2019, three customers accounted for 25.7%, 15.1% and 11.5%~~13.7% of gross accounts receivable, respectively.

Note 3 — Inventories, net

Inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first in, first out basis) or net realizable value.

Inventories, net, consisted of the following (in thousands):


		March 28, 2020		December 28, 2019			March 27, 2021		December 26, 2020
Raw materials	Raw materials	$	36,468	$	38,528	Raw materials	$	52,320	$	48,122
Work-in-progress	Work-in-progress	27,927		29,720		Work-in-progress	35,466		30,806
Finished goods	Finished goods	14,588		15,010		Finished goods	16,941		20,301
		$	78,983	$	83,258		$	104,727	$	99,229

Note 4 — Acquisition

High Precision Devices, Inc. Acquisition

On October ~~9, 2019,~~19, 2020, we acquired 100% of the shares of ~~FRT GmbH ("FRT"), a German-based company,~~HPD for total consideration of ~~$26.9~~$16.9 million, net of cash acquired of $1.7 ~~million.~~ million, which included an estimated adjustment for changes in working capital, which is not yet finalized. This acquisition brings highly specialized skills and know-how to address the unique test challenges within the emerging quantum computing, superconducting computing, and ultra-sensitive sensor markets which operate at temperatures as low as 30 millikelvin.

The acquisition was accounted for using the acquisition method of accounting, with FormFactor treated as the acquirer. The acquired assets and liabilities of HPD were recorded at their respective fair values including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the ~~purchase consideration was comprised of a $22.2 million cash payment and $6.5 million of contingent consideration.~~identifiable net assets.

Our Condensed Consolidated Statements of Income include the financial results of HPD subsequent to the acquisition date of October 19, 2020. Revenue in fiscal 2020 related to HPD subsequent to the acquisition date that was included in our Condensed Consolidated Statements of Income was not material.

The acquisition price was allocated to the tangible and identified intangible assets acquired and liabilities assumed as of the closing date of the acquisition based upon their respective fair values. The fair values assigned to assets acquired and liabilities assumed were based on management’s assumptions as of the reporting date.

We estimated the acquisition price and the allocation of fair value to assets acquired and liabilities assumed as of the acquisition date, October ~~9, 2019.~~19, 2020. We subsequently made certain immaterial adjustments within the measurement period to the preliminary acquisition price ~~allocation related to acquired assets~~allocation. See Note 5, Goodwill and ~~assumed liabilities, including to intangibles assets.~~Intangible Assets, for changes in identified intangible values and goodwill. Our purchase accounting remains open at March ~~28, 2020,~~27, 2021, subject to finalization of the fair value of

consideration and certain ~~acquired assets and liabilities.~~deferred tax items. The estimated fair value of assets acquired, including goodwill and intangibles, and liabilities assumed is as follows (in thousands):

Amount

Cash and cash equivalents

~~1,683~~1,680

Accounts receivable

~~3,057~~1,017

Inventory

~~2,643~~3,047

Property, plant and equipment

~~696~~669

Operating lease, right of use assets

~~335~~2,554

Prepaid expenses and other current assets

~~838~~599

Tangible assets acquired

9,566

Deferred revenue

~~9,252~~ (2,529)

~~Customer deposits~~

~~(2,093)~~

Accounts payable and accrued liabilities

~~(1,179)~~(1,268)

Operating lease liabilities

~~(335)~~(2,554)

Deferred tax liabilities

~~(5,843)~~(2,840)

Total tangible assets acquired and liabilities assumed

~~(198)~~375

Intangible assets

~~17,429~~11,520

Goodwill

~~11,392~~6,665

Net Assets Acquired

~~28,623~~18,560

The intangible assets as of the closing date of the acquisition included (in thousands):


		Amount		Weighted Average Useful Life (in years)		Amount		Weighted Average Useful Life (in years)
Developed technologies	Developed technologies	$	12,505	8.0	Developed technologies	$	7,500	10.0
Customer relationships	Customer relationships	3,071		6.0	Customer relationships	3,600		5.0
Backlog		1,645		0.5
Order backlog					Order backlog	200		0.5
Trade names	Trade names	208		2.0	Trade names	220		5.0
Total intangible assets	Total intangible assets	$	17,429	7.0	Total intangible assets	$	11,520	8.2

~~Indications of~~The fair value of the intangible assets acquired in connection with the acquisition ~~were~~was determined using either the income, market or replacement cost methodologies. The intangible assets are being amortized over periods which reflect the pattern in which economic benefits of the assets are expected to be realized.

The contingent consideration is a cash amount equal to 1.5x Earnings Before Interest and Tax ("EBIT") as defined in the purchase agreement, from a minimum of 0 up to a maximum of €10.3 million, payable subject to the performance of the acquired business in calendar 2020. We estimated the fair value of contingent consideration using a probability weighted approach. Key assumptions in determining the fair value of contingent consideration include estimating the probability of achieving certain EBIT levels and discounting at an appropriate discount rate.

This acquisition strengthens our leadership in test and measurement by expanding our addressable market into 3D hybrid surface metrology and extending the optical applications scope of our existing Systems segment.

Separate from the purchase agreement, on October 25, 2019, we entered into a term loan agreement with a lender for an aggregate amount of $23.4 million to finance the acquisition. The term loan agreement has not changed during the three months ended March 28, 2020 from that disclosed in our Annual Report on Form 10-K for the year ended December 28, 2019.

Identifiable Intangible Assets

Valuation of intangible assets involves multiple assumptions. The key assumptions are described below.

Developed ~~technologies~~technology acquired primarily consists of existing technology related to ~~hybrid 3D surface metrology measurement equipment.~~cryogenic probe stations, Adiabatic Demagnetization Refrigerator (“ADR”), and continuous ADR cryostats and similar tools, and technology related to other cryogenic applications. We valued the developed ~~technologies~~technology using the multi-period excess earnings method under the income approach. Using this approach, the estimated fair values were calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return.

~~Customer~~The value of customer relationships ~~represent~~represents the fair value of future projected revenues that will be derived from the sale of products to ~~FRT's~~HPD's existing customers. We valued customer relationships using the incremental cash flow method. This method estimates value based on the incremental cash flow afforded by having the customers relationships in place on the acquisition date versus having no relationships in place and needing to replicate or replace those relationships. The incremental cash flows are then discounted to a present value to arrive at an estimate of fair value for this asset class.

~~Backlog~~Order backlog represents ~~business~~the value of future sales under existing ~~contractual obligations.~~contracts as of the acquisition date. Expected cash flow from order backlog was valued on a discounted direct cash flow ~~basis.~~basis, net of returns on contributory assets such as working capital, property and equipment, trade name and assembled workforce.

The identified trade names intangibles relate to the estimated fair value of future cash flows related to the ~~FRT~~HPD brand. We valued trade names by applying the relief-from-royalty method under the income approach. This method is based on the application of a royalty rate to forecasted revenue under the trade name.

Goodwill

The excess of purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the amount of goodwill resulting from the acquisition. We believe the factors that contributed to goodwill include synergies that are specific to our consolidated business, such as cost savings and operational efficiencies, and the acquisition of a talented workforce that expands our expertise in business development and commercializing semiconductor test products, none of which qualify for recognition as a separate intangible asset. We do not expect any portion of this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition was recorded as a non-current asset and is not amortized, but is subject to an annual review for impairment.

The goodwill arising from the acquisition was allocated to the ~~FRT~~HPD reporting unit within the Systems reportable segment.

We have not presented unaudited combined pro forma financial information as the ~~FRT~~HPD acquisition was not significant to our consolidated results of operations and financial position.

Baldwin Park Acquisition

On July 30, 2020, we acquired the probe card assets of Advantest Corporation for total cash consideration of $35.0 million. This acquisition brings important enabling technologies and capabilities for designing and manufacturing advanced probe cards, and adds a complementary 3D-NAND Flash probe-card product that is qualified and in production at one of the world's leading NAND Flash manufacturers.

The acquisition was accounted for using the acquisition method of accounting, with FormFactor treated as the acquirer. The acquired assets and liabilities of Baldwin Park were recorded at their respective fair values including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets.

Our Condensed Consolidated Statements of Income include the financial results of Baldwin Park subsequent to the acquisition date of July 30, 2020. Revenue related to Baldwin Park since the acquisition date that was included in our Condensed Consolidated Statements of Income for fiscal 2020 was not material.

We estimated the acquisition price and the allocation of fair value to assets acquired and liabilities assumed as of the acquisition date, July 30, 2020. We subsequently made certain immaterial adjustments within the measurement period to the acquisition price allocation as a result of finalization of our valuation of identifiable assets and liabilities. See Note 5, Goodwill and Intangible Assets, for changes in identified intangible values and goodwill. In the current quarter ended March 27, 2021, we finalized our allocation of the assets acquired, including goodwill and intangibles, and liabilities assumed for the purchase as follows (in thousands):


	Amount
Accounts receivable	$	4,365
Inventory	2,727
Property, plant and equipment	9,053
Operating lease, right of use assets	519
Prepaid expenses and other current assets	56
Tangible assets acquired	16,720
Accounts payable and accrued liabilities	(743)
Operating lease liabilities	(519)
Total net tangible assets acquired and liabilities assumed	15,458
Intangible assets	13,600
Goodwill	5,942
Net assets acquired	$	35,000

The intangible assets as of July 30, 2020 included (in thousands):


	Amount		Weighted Average Useful Life (in years)
Developed technologies	$	8,800	10.0
Customer relationships	4,400		3.0
In-process research and development	400		N/A
Total intangible assets	$	13,600	7.7

Indications of fair value of the intangible assets acquired in connection with the acquisition were determined using either the income, market or replacement cost methodologies. The intangible assets are being amortized over periods which reflect the pattern in which economic benefits of the assets are expected to be realized.

Identifiable Intangible Assets

Valuation of intangible assets involves multiple assumptions. The key assumptions are described below.

Developed technology acquired consists of existing technology related to 3D NAND Flash probe cards and the value expected to be derived from interconnect technology. We valued the developed technology related to 3D NAND Flash using the multi-period excess earnings method under the income approach. Using this approach, the estimated fair values were calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return. We valued the interconnect developed technology asset using the incremental cash flow method. This method estimates value based on the incremental cash flow afforded by having the interconnect capability in place on the acquisition date versus having no capability in place and needing to replicate or replace that capability. The incremental cash flows are then discounted to a present value to arrive at an estimate of fair value for this asset class.

In-process research and development (“IPR&D”) acquired primarily consists of research and development projects that were in process at the time of acquisition related to technologies used in DRAM probe cards. Once these projects are complete they will be amortized over their useful life. We valued the IPR&D using the multi-period excess earnings method under the income approach. Using this approach, the estimated fair values were calculated using expected future cash flows from specific products discounted to their net present values at an appropriate risk-adjusted rate of return.

The value of customer relationships represents the fair value of future projected revenues that will be derived from the sale of products to Baldwin Park's existing customers. We valued customer relationships using the incremental cash flow method. This method estimates value based on the incremental cash flow afforded by having the customers relationships in place on the acquisition date versus having no relationships in place and needing to replicate or replace those relationships. The incremental cash flows are then discounted to a present value to arrive at an estimate of fair value for this asset class.

Goodwill

The excess of purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the amount of goodwill resulting from the acquisition. We believe the factors that contributed to goodwill include synergies that are specific to our consolidated business, such as cost savings and operational efficiencies, and the acquisition of a talented workforce that expands our expertise in business development, none of which qualify for recognition as a separate intangible asset. We expect this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition was recorded as a non-current asset and is not amortized, but is subject to an annual review for impairment.

The goodwill arising from the acquisition was allocated to the Probe Cards reporting unit within the Probe Cards reportable segment.

We have not presented unaudited combined pro forma financial information as the Baldwin Park acquisition was not significant to our consolidated results of operations and financial position.

Note 5 — Goodwill and Intangible Assets

Goodwill by reportable segment was as follows (in thousands):


		Probe Cards		Systems		Total			Probe Cards		Systems		Total
Goodwill, gross, as of December 29, 2018		$	172,482	$	16,732	$	189,214
Addition - FRT GmbH Acquisition		—		10,148		10,148
Foreign currency translation		—		(166)		(166)
Goodwill, gross, as of December 28, 2019	Goodwill, gross, as of December 28, 2019	172,482		26,714		199,196		Goodwill, gross, as of December 28, 2019	$	172,482	$	26,714	$	199,196
Addition - FRT GmbH Acquisition	Addition - FRT GmbH Acquisition	—		1,264		1,264		Addition - FRT GmbH Acquisition	0		975		975
Addition - Baldwin Park Acquisition								Addition - Baldwin Park Acquisition	5,590		0		5,590
Addition - HPD Acquisition								Addition - HPD Acquisition	0		4,654		4,654
Foreign currency translation	Foreign currency translation	—		(82)		(82)		Foreign currency translation	0		2,346		2,346
Goodwill, gross, as of March 28, 2020		$	172,482	$	27,896	$	200,378
Goodwill, gross, as of December 26, 2020								Goodwill, gross, as of December 26, 2020	178,072		34,689		212,761
Addition - Baldwin Park Acquisition								Addition - Baldwin Park Acquisition	352		0		352
Addition - HPD Acquisition								Addition - HPD Acquisition	0		2,011		2,011
Foreign currency translation								Foreign currency translation	0		(906)		(906)
Goodwill, gross, as of March 27, 2021								Goodwill, gross, as of March 27, 2021	$	178,424	$	35,794	$	214,218

NoWe have 0t recorded goodwill impairments ~~have been recorded as of~~for the three months ended March ~~28, 2020 and December 28, 2019.~~

27, 2021.

Intangible assets were as follows (in thousands):


		March 28, 2020										December 28, 2019											March 27, 2021				December 26, 2020
Intangible Assets	Intangible Assets	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net		Intangible Assets	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Developed technologies	Developed technologies	$	155,792	$	121,091	$	34,701	$	154,951	$	116,138	$	38,813	Developed technologies	$	173,318	$	142,344	$	30,974	$	176,265	$	137,754	$	38,511
Trade names	Trade names	7,809		7,046		763		7,816		6,976		840		Trade names	8,100		7,418		682		8,162		7,363		799
Customer relationships	Customer relationships	43,170		28,495		14,675		44,229		27,057		17,172		Customer relationships	51,557		34,899		16,658		52,488		33,378		19,110
Backlog	Backlog	1,670		1,670		—		1,676		891		785		Backlog	1,969		1,897		72		2,227		1,900		327
In-process research and development														In-process research and development	400		0		400		400		0		400
		$	208,441	$	158,302	$	50,139	$	208,672	$	151,062	$	57,610		$	235,344	$	186,558	$	48,786	$	239,542	$	180,395	$	59,147

Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Cost of revenues	Cost of revenues	$	5,750	$	4,719	Cost of revenues	$	5,090	$	5,750
Selling, general and administrative	Selling, general and administrative	1,513		2,371		Selling, general and administrative	1,715		1,513
		$	7,263	$	7,090		$	6,805	$	7,263

The estimated future amortization of definite-lived intangible assets, excluding in-process research and development, is as follows (in thousands):


Fiscal Year	Fiscal Year	Amount		Fiscal Year	Amount
Remainder of 2020		$	19,021
2021		14,767
Remainder of 2021				Remainder of 2021	$	11,933
2022	2022	5,585		2022	9,591
2023	2023	3,846		2023	7,240
2024	2024	2,107		2024	4,625
2025				2025	4,364
Thereafter	Thereafter	4,813		Thereafter	10,633
		$	50,139		$	48,386

Note 6 — Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):


		March 28, 2020		December 28, 2019			March 27, 2021		December 26, 2020
Accrued compensation and benefits	Accrued compensation and benefits	$	18,435	$	21,329	Accrued compensation and benefits	$	28,092	$	33,110
Accrued income and other taxes	Accrued income and other taxes	4,519		6,846		Accrued income and other taxes	3,008		6,976
Accrued warranty	Accrued warranty	1,918		1,942		Accrued warranty	3,719		3,918
Accrued employee stock purchase plan contributions withheld		1,585		3,331
Employee stock purchase plan contributions withheld						Employee stock purchase plan contributions withheld	2,109		4,240
Accrued contingent consideration						Accrued contingent consideration	3,884		4,012
Other accrued expenses	Other accrued expenses	2,718		2,991		Other accrued expenses	2,656		3,086
		$	29,175	$	36,439		$	43,468	$	55,342

Note 7 — Fair Value and Derivative Instruments

Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows:

•Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities;

•Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

•Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances.

We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three months ended March ~~28, 2020~~27, 2021 or the year ended December ~~28, 2019.~~26, 2020.

The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable, Accrued liabilities, and ~~Current portion of~~ term loans, net of unamortized issuance costs, approximate fair value due to their short maturities.

No changes were made to our valuation techniques during the first three months of fiscal ~~2020.~~2021.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):


March 28, 2020		Level 1		Level 2		Level 3		Total
March 27, 2021										March 27, 2021	Level 1		Level 2		Level 3		Total
Assets:	Assets:									Assets:
Cash equivalents:	Cash equivalents:									Cash equivalents:
Money market funds	Money market funds	$	74,992	$	—	$	—	$	74,992	Money market funds	$	34,254	$	0	$	0	$	34,254

Commercial paper										Commercial paper	5,500		0		0		5,500

											39,754		0		0		39,754
Marketable securities:	Marketable securities:									Marketable securities:
U.S. treasuries	U.S. treasuries	30,873		—		—		30,873		U.S. treasuries	32,669		0		0		32,669
Certificates of deposit	Certificates of deposit	—		3,841		—		3,841		Certificates of deposit	0		1,212		0		1,212
U.S. agency securities	U.S. agency securities	—		3,751		—		3,751		U.S. agency securities	0		575		0		575
Corporate bonds	Corporate bonds	—		28,657		—		28,657		Corporate bonds	0		44,146		0		44,146
Commercial paper	Commercial paper	—		2,637		—		2,637		Commercial paper	0		15,491		0		15,491
		30,873		38,886		—		69,759			32,669		61,424		0		94,093
Foreign exchange derivative contracts		—		4		—		4

Foreign exchange derivative contracts (Designated)										Foreign exchange derivative contracts (Designated)	0		144		0		144
Interest rate swap derivative contracts										Interest rate swap derivative contracts	0		745		0		745
Total assets	Total assets	$	105,865	$	38,890	$	—	$	144,755	Total assets	$	72,423	$	62,313	$	0	$	134,736
Liabilities:	Liabilities:									Liabilities:
Foreign exchange derivative contracts		$	—	$	(154)	$	—	$	(154)
Foreign exchange derivative contracts (Designated)										Foreign exchange derivative contracts (Designated)	$	0	$	(100)	$	0	$	(100)
Interest rate swap derivative contracts	Interest rate swap derivative contracts	—		(93)		—		(93)		Interest rate swap derivative contracts	0		(113)		0		(113)
Contingent consideration	Contingent consideration	—		—		(6,515)		(6,515)		Contingent consideration	0		0		(3,884)		(3,884)
Total liabilities	Total liabilities	$	—	$	(247)	$	(6,515)	$	(6,762)	Total liabilities	$	0	$	(213)	$	(3,884)	$	(4,097)


December 28, 2019		Level 1		Level 2		Level 3		Total
December 26, 2020										December 26, 2020	Level 1		Level 2		Level 3		Total
Assets:	Assets:									Assets:
Cash equivalents:	Cash equivalents:									Cash equivalents:
Money market funds	Money market funds	$	17,056	$	—	$	—	$	17,056	Money market funds	$	43,019	$	0	$	0	$	43,019

Marketable securities:	Marketable securities:									Marketable securities:
U.S. treasuries	U.S. treasuries	10,468		—		—		10,468		U.S. treasuries	40,726		0		0		40,726
Certificates of deposit	Certificates of deposit	—		3,590		—		3,590		Certificates of deposit	0		2,179		0		2,179
U.S. agency securities	U.S. agency securities	—		24,430		—		24,430		U.S. agency securities	0		575		0		575
Corporate bonds	Corporate bonds	—		33,928		—		33,928		Corporate bonds	0		24,330		0		24,330
Commercial paper		—		3,911		—		3,911

		10,468		65,859		—		76,327			40,726		27,084		0		67,810
Foreign exchange derivative contracts	Foreign exchange derivative contracts	—		41		—		41		Foreign exchange derivative contracts	0		1,057		0		1,057
Interest rate swap derivative contracts	Interest rate swap derivative contracts	—		26		—		26		Interest rate swap derivative contracts	0		57		0		57
Total assets	Total assets	$	27,524	$	65,926	$	—	$	93,450	Total assets	$	83,745	$	28,198	$	0	$	111,943
Liabilities:	Liabilities:									Liabilities:
Foreign exchange derivative contracts		$	—	$	(240)	$	—	$	(240)

Interest rate swap derivative contracts										Interest rate swap derivative contracts	$	0	$	(87)	$	0	$	(87)
Contingent consideration	Contingent consideration	—		—		(5,364)		(5,364)		Contingent consideration	0		0		(4,012)		(4,012)
Total liabilities	Total liabilities	$	—	$	(240)	$	(5,364)	$	(5,604)	Total liabilities	$	0	$	(87)	$	(4,012)	$	(4,099)

Cash Equivalents

The fair value of our cash equivalents is determined based on quoted market prices for similar or identical securities.

Marketable Securities

We classify our marketable securities as available-for-sale and value them utilizing a market approach. Our investments are priced by pricing vendors who provide observable inputs for their pricing without applying significant judgment. Broker pricing is used mainly when a quoted price is not available, the investment is not priced by our pricing vendors or when a broker price

is more reflective of fair value. Our broker-priced investments are categorized as Level 2 investments because fair value is based on similar assets without applying significant judgments. In addition, all investments have a sufficient trading volume to demonstrate that the fair value is appropriate.

Unrealized gains and losses were immaterial and were recorded as a component of Accumulated other comprehensive income in our Condensed Consolidated Balance Sheets. We did not have any other-than-temporary unrealized gains or losses at either period end included in these financial statements.

Contingent Consideration

Contingent consideration, arising from the acquisition of FRT, ~~(see Note 4),~~ is a cash amount equal to 1.5x EBIT as defined in the purchase agreement, up to a maximum of €10.3 million, payable subject to the performance of the acquired business in calendar 2020. We estimated the fair value of contingent consideration using a probability weighted approach. Key assumptions in determining the fair value of contingent consideration ~~include~~included estimating ~~the probability of achieving certain~~ EBIT levels that we believed as of the acquisition date were likely to be achieved during the performance period and discounting at an appropriate discount rate. Contingent consideration as of March ~~28,~~27, 2021 was estimated to be $3.9 million, with the change from December 26, 2020 ~~was $6.5 million and which increased by $1.1 million~~resulting from ~~$5.4 million as of December 28, 2019 as a result of subsequent immaterial adjustments.~~foreign currency translation.

Interest Rate Swaps

The fair value of our interest rate swap contracts is determined at the end of each reporting period based on valuation models that use interest rate yield curves as inputs. For accounting purposes, our interest rate swap contracts qualify for, and are designated as, cash flow hedges. The cash flows associated with the interest rate swaps are reported in Net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows and the fair value of the interest rate swap contracts are recorded within ~~Prepaid expenses~~Accrued liabilities and ~~other current assets~~Other liabilities in our Condensed Consolidated Balance Sheets.

The impact of the interest rate swaps on our Condensed Consolidated Statements of Income was as follows (in thousands):


		Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)		Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)	Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)			Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)		Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)	Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)
Three Months Ended March 27, 2021										Three Months Ended March 27, 2021	$	624	Interest expense	$	(38)	Interest expense	$	—
Three Months Ended March 28, 2020	Three Months Ended March 28, 2020	$	(96)	Interest expense, net	$	22	Interest expense, net	$	—	Three Months Ended March 28, 2020	$	(96)	Interest expense	$	22	Interest expense	$	—
Three Months Ended March 30, 2019		$	(28)	Interest expense, net	$	(208)	Interest expense, net	$	—

Foreign Exchange Derivative Contracts

We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We utilize foreign currency forward contracts to hedge against future movements in foreign exchange rates that affect certain existing foreign currency denominated assets and liabilities and forecasted foreign currency revenue and expense transactions. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses.

We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, certain of our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded within Other ~~expense,~~income (expense), net in our Condensed Consolidated Statement of Income for both realized and unrealized gains and losses. Certain of our foreign currency forward contracts are designated as cash flow hedges, and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded as a component of Accumulated other comprehensive ~~loss~~income and reclassified into earnings in the same period in which the hedged transaction affects earnings, and in the same line item on the Condensed Consolidated Statements of Income as the impact of the hedge transaction. At March 28, 2020, we expect to reclassify $0.2 million of the amount accumulated in Other comprehensive loss to earnings during the next 12 months, due to the recognition in earnings of the hedged forecasted transactions.

The fair value of our foreign exchange derivative contracts was determined based on current foreign currency exchange rates and forward points. All of our foreign exchange derivative contracts outstanding at March ~~28, 2020~~27, 2021 will mature by the ~~second~~first quarter of fiscal ~~2021.~~2022.

The following table provides information about our foreign currency forward contracts outstanding as of March ~~28, 2020~~27, 2021 (in thousands):


Currency	Currency	Contract Position	Contract Amount (Local Currency)	Contract Amount (U.S. Dollars)		Currency	Contract Position	Contract Amount (Local Currency)	Contract Amount (U.S. Dollars)
Euro Dollar	Euro Dollar	Buy	(3,061)	$	(3,557)	Euro Dollar	Buy	(10,141)	$	(12,025)
Euro Dollar						Euro Dollar	Sell	11,043	13,026
Japanese Yen	Japanese Yen	Sell	1,346,506	12,503		Japanese Yen	Buy	(1,971,765)	(17,977)
Korean Won	Korean Won	Buy	(2,526,325)	(2,088)		Korean Won	Sell	3,129,743	2,767

Taiwan Dollar						Taiwan Dollar	Sell	7,972	279

Total USD notional amount of outstanding foreign exchange contracts	Total USD notional amount of outstanding foreign exchange contracts			$	6,858	Total USD notional amount of outstanding foreign exchange contracts			$	(13,930)

Our foreign currency contracts are classified within Level 2 of the fair value hierarchy as they are valued using pricing models that utilize observable market inputs.

The impact of foreign exchange derivative contracts not designated as cash flow hedges on our Condensed Consolidated Statements of Income was as follows (in thousands):

Amount of Gain (Loss) Recognized on Derivatives
Three Months Ended
Derivatives Not Designated as Hedging Instruments Location of Gain (Loss) Recognized on Derivatives March 28, 2020 March 30, 2019
Foreign exchange forward contracts Other expense, net $ (115) $ 314

Amount of Gain (Loss) Recognized on Derivatives

Three Months Ended

Derivatives Not Designated as Hedging Instruments

Location of Gain (Loss) Recognized on Derivatives

March 27,
2021

March 28,
2020

Foreign exchange forward contracts

Other income (expense), net

1,288

(115)

The impact of foreign exchange derivative contracts designated as cash flow hedges on our Condensed Consolidated Statements of Income was as follows (in thousands):


	Amount of Loss Recognized in Accumulated OCI on Derivative		Location of Loss Reclassified from Accumulated OCI into Income	Amount of Loss Reclassified from Accumulated OCI into Income			Amount of Gain (Loss) Recognized in Accumulated OCI on Derivative		Location of Gain (Loss) Reclassified from Accumulated OCI into Income	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Three Months Ended March 28, 2020	$	(3)	Cost of revenues	$	(120)
Three Months Ended March 27, 2021						Three Months Ended March 27, 2021	$	(526)	Cost of revenues	$	250
			Research and development	(18)					Research and development	30
			Selling, general and administrative	(43)					Selling, general and administrative	82
				$	(181)					$	362

Three Months Ended March 30, 2019	$	(435)	Cost of revenues	$	(32)
Three Months Ended March 28, 2020						Three Months Ended March 28, 2020	$	(3)	Cost of revenues	$	(120)
			Research and development	(19)					Research and development	(18)
			Selling, general and administrative	(7)					Selling, general and administrative	(43)
				$	(58)					$	(181)

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

We measure and report our non-financial assets such as Property, plant and equipment, Goodwill and Intangible assets at fair value on a non-recurring basis if we determine these assets to be impaired or in the period when we make a business acquisition. Other than as discussed in Note 4, Acquisition, there were 0 assets or liabilities measured at fair value on a nonrecurring basis during the three months ended March ~~28, 2020~~27, 2021 or March ~~30, 2019.~~28, 2020.

Note 8 — Warranty

We offer warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based upon historical experience and our estimate of the level of future costs. While we engage in product quality programs and processes, our warranty obligation is affected by product failure rates,

material usage and service delivery costs. We continuously monitor product returns for warranty and maintain a reserve for the related expenses based upon our historical experience and any specifically identified failures. As we sell new products to our customers, we must exercise considerable judgment in estimating the expected failure rates. This estimating process is based on historical experience of similar products, as well as various other assumptions that we believe to be reasonable under the circumstances. We provide for the estimated cost of product warranties at the time revenue is recognized as a component of Cost of revenues in our Condensed Consolidated Statement of Income.

Changes in our warranty liability were as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Balance at beginning of period	Balance at beginning of period	$	1,942	$	2,102	Balance at beginning of period	$	3,918	$	1,942
Accruals	Accruals	660		889		Accruals	1,374		660
Settlements	Settlements	(684)		(970)		Settlements	(1,573)		(684)
Balance at end of period	Balance at end of period	$	1,918	$	2,021	Balance at end of period	$	3,719	$	1,918

Note 9 — Property, Plant and Equipment, net

Property, plant and equipment, net consisted of the following (in thousands):


	March 27, 2021		December 26, 2020
Land	$	4,751	$	4,751
Machinery and equipment	233,357		226,185
Computer equipment and software	43,839		36,361
Furniture and fixtures	6,925		6,894
Leasehold improvements	80,011		79,144
Sub-total	368,883		353,335
Less: Accumulated depreciation and amortization	(298,865)		(294,468)
Net, property, plant and equipment	70,018		58,867
Construction-in-process	42,294		45,236
Total	$	112,312	$	104,103

Note 10 — Stockholders’ Equity and Stock-Based Compensation

Common Stock Repurchase Program

On October 26, 2020, our Board of Directors authorized a program to repurchase up to $50 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation plans. The share repurchase program will expire on October 28, 2022. During the three months ended March 27, 2021, we repurchased 136,402 shares of common stock for $5.7 million and, as of March 27, 2021, $44.3 million remained available for future repurchases.

Our policy related to repurchases of our common stock is to charge the excess of cost over par value to additional paid-in capital once the shares are retired. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Restricted Stock Units

Restricted stock unit ~~("RSU"~~(“RSU”) activity under our equity incentive plan was as follows:

Units Weighted Average Grant Date Fair Value
RSUs at December 28, 2019 3,069,000 $ 14.30
Awards granted 16,000 26.05
Awards vested (43,604) 12.70
Awards forfeited (20,291) 14.25
RSUs at March 28, 2020 3,021,105 $ 14.39

~~The total fair value of RSUs vested during the three months ended March 28, 2020 was $1.0 million.~~


	Units	Weighted Average Grant Date Fair Value
RSUs at December 26, 2020	2,840,922	$	19.80
Awards granted	8,765	46.25
Awards vested	(67,635)	16.38
Awards forfeited	(11,140)	21.21
RSUs at March 27, 2021	2,770,912	19.96

Performance Restricted Stock Units

We may grant Performance RSUs ~~("PRSUs"~~(“PRSUs”) to certain executives, which vest based upon us achieving certain market performance criteria. There were no0 PRSUs granted during the three months ended March ~~28, 2020.~~27, 2021. PRSUs are included as part of the RSU activity above.

Stock Options

Stock option activity under our equity incentive plan was as follows:

Options Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Life in Years Aggregate Intrinsic Value
Outstanding at December 28, 2019 361,769 $ 8.35
Options exercised (55,769) 8.01
Outstanding at March 28, 2020 306,000 $ 8.41 1.88 $ 3,607,620
Vested and expected to vest at March 28, 2020 306,000 $ 8.41 1.88 $ 3,607,620
Exercisable at March 28, 2020 306,000 $ 8.41 1.88 $ 3,607,620


	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at December 26, 2020	106,000	$	8.35

Options exercised	(50,000)	8.44

Outstanding at March 27, 2021	56,000	$	8.28	0.92	$	2,078,820
Vested and expected to vest at March 27, 2021	56,000	$	8.28	0.92	$	2,078,820
Exercisable at March 27, 2021	56,000	$	8.28	0.92	$	2,078,820

Employee Stock Purchase Plan

Information related to activity under our Employee Stock Purchase Plan ~~("ESPP"~~(“ESPP”) was as follows:


	Three Months Ended
	March ~~28, 2020~~27, 2021
Shares issued	~~311,591~~228,784
Weighted average per share purchase price	$	~~13.05~~22.14
Weighted average per share discount from the fair value of our common stock on the date of issuance	$	~~12.26~~ (18.73)

Stock-Based Compensation

Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Cost of revenues	Cost of revenues	$	937	$	950	Cost of revenues	$	1,335	$	937
Research and development	Research and development	1,439		1,519		Research and development	1,689		1,439
Selling, general and administrative	Selling, general and administrative	3,247		2,826		Selling, general and administrative	4,053		3,247
Total stock-based compensation	Total stock-based compensation	$	5,623	$	5,295	Total stock-based compensation	$	7,077	$	5,623

1720

Unrecognized Compensation Costs

At March ~~28, 2020,~~27, 2021, the unrecognized stock-based compensation was as follows (dollars in thousands):


		Unrecognized Expense		Average Expected Recognition Period in Years		Unrecognized Expense		Average Expected Recognition Period in Years

Restricted stock units	Restricted stock units	$	20,158	1.79	Restricted stock units	$	27,429	2.03
Performance restricted stock units	Performance restricted stock units	5,544		1.79	Performance restricted stock units	7,719		1.93
Employee stock purchase plan	Employee stock purchase plan	662		0.85	Employee stock purchase plan	973		0.86
Total unrecognized stock-based compensation expense	Total unrecognized stock-based compensation expense	$	26,364	1.77	Total unrecognized stock-based compensation expense	$	36,121	1.99

Note 1011 — Net Income per Share

The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands):


		Three Months Ended				Three Months Ended
		March 28, 2020	March 30, 2019		March 27, 2021	March 28, 2020

Weighted-average shares used in computing basic net income per share	Weighted-average shares used in computing basic net income per share	76,005	74,362	Weighted-average shares used in computing basic net income per share	77,598	76,005
Add potentially dilutive securities	Add potentially dilutive securities	2,505	1,647	Add potentially dilutive securities	2,390	2,505
Weighted-average shares used in computing diluted net income per share	Weighted-average shares used in computing diluted net income per share	78,510	76,009	Weighted-average shares used in computing diluted net income per share	79,988	78,510

Securities not included as they would have been antidilutive	Securities not included as they would have been antidilutive	9	38	Securities not included as they would have been antidilutive	3	9

Note 1112 — Commitments and Contingencies

Leases

See Note ~~12.~~13, Leases.

Contractual Obligations and Commitments

Our contractual obligations and commitments have not materially changed as of March ~~28, 2020~~27, 2021 from those disclosed in our Annual Report on Form 10-K for the year ended December ~~28, 2019.~~26, 2020.

Legal Matters

From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. As of March ~~28, 2020,~~27, 2021, and as of the filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.

Note 1213 — Leases

We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space, as well as for our corporate headquarters located in Livermore, California. Our leases have remaining terms of 1 to 158 years, and some leases include options to extend up to 20 years. We also have operating leases for automobiles with remaining lease terms of 1 to 4 years. We did not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility and we are not reasonably certain we will exercise these options at this time. The weighted-average remaining lease term for our operating leases was 86 years as of March ~~28, 2020~~27, 2021 and the weighted-average discount rate was ~~4.40%~~3.85%.

1821

The components of lease expense were as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Lease expense:	Lease expense:					Lease expense:
Operating lease expense	Operating lease expense	$	1,924	$	1,745	Operating lease expense	$	2,123	$	1,924
Short-term lease expense	Short-term lease expense	40		17		Short-term lease expense	37		40
Variable lease expense	Variable lease expense	383		419		Variable lease expense	537		383
		$	2,347	$	2,181		$	2,697	$	2,347

Future minimum payments under our non-cancelable operating leases were as follows as of March ~~28, 2020~~27, 2021 (in thousands):


Fiscal Year	Fiscal Year	Amount		Fiscal Year	Amount
Remainder of 2020		$	5,692
2021		6,713
Remainder of 2021				Remainder of 2021	$	6,747
2022	2022	5,546		2022	8,040
2023	2023	4,934		2023	6,710
2024	2024	4,769		2024	6,297
2025				2025	7,814
Thereafter	Thereafter	22,165		Thereafter	14,416
Total minimum lease payments	Total minimum lease payments	49,819		Total minimum lease payments	50,024
Less: interest	Less: interest	(8,976)		Less: interest	(8,982)
Present value of net minimum lease payments	Present value of net minimum lease payments	40,843		Present value of net minimum lease payments	41,042
Less: current portion	Less: current portion	(6,815)		Less: current portion	(7,557)
Total long-term operating lease liabilities	Total long-term operating lease liabilities	$	34,028	Total long-term operating lease liabilities	$	33,485

Note 1314 — Revenue

Transaction price allocated to the remaining performance obligations: On March ~~28, 2020,~~27, 2021, we had ~~$4.0~~$6.3 million of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts and contracts with overtime revenue recognition that are not yet delivered. We expect to recognize approximately ~~70%~~74.5% of our remaining performance obligations as revenue in the remainder of fiscal ~~2020,~~2021, approximately ~~19%~~16.6% in fiscal ~~2021,~~2022, and approximately ~~11%~~8.9% in fiscal ~~2022~~2023 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.

Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for doubtful accounts. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of March ~~28, 2020~~27, 2021 and December ~~28, 2019~~26, 2020 were ~~$2.6~~$4.8 million and ~~$0.9~~$3.7 million, respectively, and are reported on the Condensed Consolidated Balance Sheets as a component of Prepaid expenses and other current assets.

Contract liabilities include payments received in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of Deferred revenue and Other liabilities. Contract liabilities as of March ~~28, 2020~~27, 2021 and December ~~28, 2019~~26, 2020 were ~~$10.7~~$19.9 million and ~~$10.8~~$22.2 million, respectively. During the three months ended March ~~28, 2020,~~27, 2021, we recognized ~~$5.8~~$9.3 million of revenue, that was included in contract liabilities as of December ~~28, 2019.~~26, 2020.

Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense, as the amortization period is typically less than one year.

Revenue by Category: Refer to Note ~~14 of Notes to Condensed Consolidated Financial Statements~~15, Operating Segments and Enterprise-Wide Information, for further details.

Note 1415 — Operating Segments and Enterprise-Wide Information

Our chief operating decision maker ~~("CODM"~~(“CODM”) is our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. We operate in 2 reportable segments consisting of the Probe Cards segment and the Systems segment. The following table summarizes the operating results by reportable segment (dollars in thousands):


		Three Months Ended																																														Three Months Ended
		March 28, 2020																					March 30, 2019																						March 27, 2021						March 28, 2020
		Probe Cards			Systems			Corporate and Other			Total			Probe Cards			Systems			Corporate and Other			Total				Probe Cards			Systems			Corporate and Other			Total			Probe Cards			Systems			Corporate and Other			Total
Revenues	Revenues	$	134,715		$	26,038		$	—		$	160,753		$	108,103		$	24,110		$	—		$	132,213		Revenues	$	158,898		$	27,738		$	0		$	186,636		$	134,715		$	26,038		$	0		$	160,753
Gross profit	Gross profit	$	60,743		$	13,334		$	(6,687)		$	67,390		$	45,294		$	13,016		$	(5,789)		$	52,521		Gross profit	$	70,315		$	13,599		$	(7,208)		$	76,706		$	60,743		$	13,334		$	(6,687)		$	67,390
Gross margin	Gross margin	45.1		%	51.2		%	—		%	41.9		%	41.9		%	54.0		%	—		%	39.7		%	Gross margin	44.3		%	49.0		%	0		%	41.1		%	45.1		%	51.2		%	0		%	41.9		%

Operating results provide useful information to our management for assessment of our performance and results of operations. Certain components of our operating results are utilized to determine executive compensation along with other measures.

Corporate and Other includes unallocated expenses relating to amortization of intangible assets, inventory and fixed asset fair value adjustments due to acquisitions and share-based compensation, ~~and restructuring charges, net,~~ which are not used in evaluating the results of, or in allocating resources to, our reportable segments.

Certain revenue category information by reportable segment was as follows (in thousands):


		Three Months Ended																							Three Months Ended
		March 28, 2020										March 30, 2019											March 27, 2021				March 28, 2020
		Probe Cards		Systems		Total		Probe Cards		Systems		Total			Probe Cards		Systems		Total		Probe Cards		Systems		Total
Market:	Market:													Market:
Foundry & Logic	Foundry & Logic	$	105,745	$	—	$	105,745	$	71,580	$	—	$	71,580	Foundry & Logic	$	113,410	$	0	$	113,410	$	105,745	$	0	$	105,745
DRAM	DRAM	24,696		—		24,696		28,886		—		28,886		DRAM	33,898		0		33,898		24,696		0		24,696
Flash	Flash	4,274		—		4,274		7,637		—		7,637		Flash	11,590		0		11,590		4,274		0		4,274
Systems	Systems	—		26,038		26,038		—		24,110		24,110		Systems	0		27,738		27,738		0		26,038		26,038
Total	Total	$	134,715	$	26,038	$	160,753	$	108,103	$	24,110	$	132,213	Total	$	158,898	$	27,738	$	186,636	$	134,715	$	26,038	$	160,753
Timing of revenue recognition:	Timing of revenue recognition:													Timing of revenue recognition:
Products transferred at a point in time	Products transferred at a point in time	$	134,069	$	24,858	$	158,927	$	107,491	$	23,142	$	130,633	Products transferred at a point in time	$	158,476	$	24,671	$	183,147	$	134,069	$	24,858	$	158,927
Services transferred over time		646		1,180		1,826		612		968		1,580
Products and services transferred over time														Products and services transferred over time	422		3,067		3,489		646		1,180		1,826
Total	Total	$	134,715	$	26,038	$	160,753	$	108,103	$	24,110	$	132,213	Total	$	158,898	$	27,738	$	186,636	$	134,715	$	26,038	$	160,753
Geographical region:	Geographical region:													Geographical region:
Taiwan														Taiwan	$	44,734	$	846	$	45,580	$	30,439	$	1,341	$	31,780
China	China	$	37,280	$	6,362	$	43,642	$	18,151	$	3,692	$	21,843	China	37,831		4,794		42,625		37,280		6,362		43,642
United States	United States	25,611		6,305		31,916		27,655		6,608		34,263		United States	21,308		8,178		29,486		25,611		6,305		31,916
Taiwan		30,439		1,341		31,780		21,257		1,130		22,387
Asia-Pacific1														Asia-Pacific1	27,878		1,080		28,958		4,455		3,408		7,863
South Korea														South Korea	18,001		1,084		19,085		13,692		396		14,088
Europe	Europe	16,210		4,833		21,043		5,373		4,120		9,493		Europe	2,833		7,166		9,999		16,210		4,833		21,043
South Korea		13,692		396		14,088		25,018		1,705		26,723
Japan	Japan	5,535		2,835		8,370		5,300		5,132		10,432		Japan	5,249		4,072		9,321		5,535		2,835		8,370
Asia-Pacific¹		4,455		3,408		7,863		2,790		473		3,263
Rest of the world	Rest of the world	1,493		558		2,051		2,559		1,250		3,809		Rest of the world	1,064		518		1,582		1,493		558		2,051
Total	Total	$	134,715	$	26,038	$	160,753	$	108,103	$	24,110	$	132,213	Total	$	158,898	$	27,738	$	186,636	$	134,715	$	26,038	$	160,753

1 Asia-Pacific includes all countries in the region except China, Japan, South Korea, and Taiwan, which are disclosed separately.

2023

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, which are subject to risks and uncertainties. The forward-looking statements include statements concerning, among other things, our business strategy, financial and operating results, gross margins, liquidity and capital expenditure requirements and impact of accounting standards. In some cases, you can identify these statements by forward-looking words, such as ~~"may," "might," "will," "could," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "intend"~~“may,” “might,” “will,” “could,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “intend” and ~~"continue,"~~“continue,” the negative or plural of these words and other comparable terminology.

The forward-looking statements are only predictions based on our current expectations and our projections about future events. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to us as of the filing date of this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward-looking statements. We have no obligation to update any of these statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements, including risks related to general market trends, the benefits of acquisitions and investments, uncertainties related to COVID-19 and the impact of our responses to it, the interpretation and impacts of changes in export controls and other trade barriers, our ability to execute our business strategy and other risks discussed in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December ~~28, 2019~~26, 2020 and in this Quarterly Report on Form 10-Q. You should carefully consider the numerous risks and uncertainties described under these sections.

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes contained in this Quarterly Report on Form 10-Q. Unless expressly stated or the context otherwise requires, the terms “we,” “our,” “us” and “FormFactor” refer to FormFactor, Inc. and its subsidiaries.

Overview

FormFactor, Inc., headquartered in Livermore, California, is a leading provider of test and measurement ~~solutions.~~technologies. We provide a broad range of high-performance probe cards, analytical probes, probe stations, metrology systems, thermal systems and ~~thermal sub-systems~~cryogenic systems to both semiconductor companies and scientific institutions. Our products provide electrical and ~~optical~~physical information from a variety of semiconductor and electro-optical devices and integrated circuits from early research, through development, to high-volume production. Customers use our products and services to lower production costs, improve yields, and enable development of their complex next-generation products.

We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment. Sales of our probe cards and analytical probes are included in the Probe Cards segment, while sales of our probe stations, metrology systems, and thermal ~~sub-systems~~and cryogenic systems are included in the Systems segment.

We generated net income of $19.6 million in the first three months of fiscal 2021 as compared to $15.9 million in the first three months of fiscal ~~2020 as compared to $5.5 million in the first three months of fiscal 2019.~~2020. The increase in net income was primarily due to ~~higher~~increased revenues, partially offset by higher operating ~~expenses, both generated by higher operating levels.~~expenses.

Impact of COVID-19

An outbreak of an illness caused by a novel coronavirus in 2019 (“COVID-19”) has resulted in millions of infections and well over one hundred thousand deaths worldwide as of the date of filing this Quarterly Report.The COVID-19 pandemic continues to ~~spread~~cause serious illness and death in many of the regions that we, our customers and our suppliers operate. The COVID-19 pandemic has resulted in significant governmental ~~measures being implemented~~actions designed to control the spread of the virus, including the imposition of ~~stay-at-home~~safety requirements and other orders in locations where we have manufacturing and other activities. We ~~experienced a significant disruption~~have maintained social distancing, contact tracing, and various other measures to enable our ~~operations as a result of the COVID-19 pandemic during the last two weeks of our first fiscal quarter of 2020 which continues, although currently~~manufacturing sites to ~~a lessening extent.~~continue efficient production.

We believe that we operate in a critical infrastructure industry, as defined by the U.S. Department of Homeland Security. This reduces the current and anticipated impacts of the COVID-19 pandemic on our major customers and suppliers, and upon our operations, as compared to companies that are not part of the critical infrastructure. After a temporary suspension of manufacturing to implement safety measures in our California and Oregon locations, consistent with federal guidelines and state and local orders, we recommenced manufacturing. We currently continue to operate in all of our manufacturing sites

at production levels comparable to those prior to the pandemic, albeit subject to certain safety and related constraints. Our other operations are similarly continuing with substantial work-from-home activities.

If the provisions of governmental health orders or other safety requirements ~~continue~~applicable to us or our customers or suppliers become more restrictive for an extended period of time, or if we have repeated occurrences of COVID-19 in any of our facilities, we may experience ~~further~~ disruptions or delays in manufacturing, product design, product development, customer support, manufacturing and sales, and an overall loss of productivity and efficiency. The progression of the COVID-19 pandemic could also negatively impact our business or results of operations through new restrictions at our operating locations or at those of our customers or suppliers.

Even with our continued operations, COVID-19 has had, and may have further, negative impacts on our supply chain, workforce and customers. As the COVID-19 pandemic is a widespread public health crisis, it is also adversely affecting major economies and financial markets world-wide. A resulting economic downturn can be expected to eventually negatively affect the demand for our products, and contribute to volatile demand and supply conditions affecting the markets for our products.

Governments in several countries where we operate, including the United States, have enacted stabilization and stimulus measures in an effort to counteract some of the impacts of COVID-19. We may benefit from some of these measures, although we do not believe those benefits will have a material effect upon our financial results or financial condition.

While to date the disruptions in our operations, supply chain and customer demand as a result of the COVID-19 pandemic have been somewhat limited, we believe that the COVID-19 pandemic represents a sustained threat that may ~~eventually~~ give rise to a variety of more significant adverse impacts on our business and financial results. We consider this as a near or longer term trend, although we cannot identify or quantify the specific impacts given current levels of uncertainty and the broad variety of effects that may arise from a pandemic of this magnitude. For a further description of the uncertainties and business risks associated with the COVID-19 pandemic, see the ~~section entitled “Risk Factors”~~risk factors discussed in ~~this Quarterly Report.~~our Annual Report on Form 10-K for the year ended December 26, 2020.

~~Critical~~Significant Accounting Policies and the Use of Estimates

Management’s Discussion and Analysis and Note 2, Summary of Significant Accounting Policies, to the Consolidated Financial Statements in our ~~2019~~2020 Annual Report on Form 10-K describe the significant accounting estimates and ~~critical~~significant accounting policies used in preparation of the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates. During the three months ended March ~~28, 2020,~~27, 2021, there were no significant changes in our ~~critical~~significant accounting policies or estimates from those reported in our Annual Report on Form 10-K for the year ended December ~~28, 2019,~~26, 2020, which was filed with the Securities and Exchange Commission on February ~~21, 2020.~~22, 2021.

Results of Operations

The following table sets forth our operating results as a percentage of revenues for the periods indicated:


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
Revenues	Revenues	100.0	%	100.0	%	Revenues	100.0	%	100.0	%
Cost of revenues	Cost of revenues	58.1		60.3		Cost of revenues	58.9		58.1
Gross profit	Gross profit	41.9		39.7		Gross profit	41.1		41.9
Operating expenses:	Operating expenses:					Operating expenses:
Research and development	Research and development	13.2		14.9		Research and development	12.9		13.2
Selling, general and administrative	Selling, general and administrative	17.2		19.0		Selling, general and administrative	16.1		17.2

Total operating expenses	Total operating expenses	30.4		33.9		Total operating expenses	29.0		30.4
Operating income	Operating income	11.5		5.8		Operating income	12.1		11.5
Interest income	Interest income	0.4		0.4		Interest income	0.1		0.4
Interest expense	Interest expense	(0.2)		(0.5)		Interest expense	(0.1)		(0.2)
Other expense, net		(0.1)		(0.1)
Other income (expense), net						Other income (expense), net	0.1		(0.1)
Income before income taxes	Income before income taxes	11.6		5.6		Income before income taxes	12.2		11.6
Provision for income taxes	Provision for income taxes	1.8		1.5		Provision for income taxes	1.7		1.8
Net income	Net income	9.8	%	4.1	%	Net income	10.5	%	9.8	%

Revenues by Segment and Market


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
		(In thousands)							(In thousands)
Probe Cards	Probe Cards	$	134,715	$	108,103	Probe Cards	$	158,898	$	134,715
Systems	Systems	26,038		24,110		Systems	27,738		26,038
		$	160,753	$	132,213		$	186,636	$	160,753

Three Months Ended
March 28,
2020 % of Revenues March 30,
2019 % of Revenues $ Change % Change
(Dollars in thousands)
Probe Cards Markets:
Foundry & Logic $ 105,745 65.8 % $ 71,580 54.1 % $ 34,165 47.7 %
DRAM 24,696 15.4 28,886 21.9 (4,190) (14.5)
Flash 4,274 2.7 7,637 5.8 (3,363) (44.0)
Systems Market:
Systems 26,038 16.1 24,110 18.2 1,928 8.0
Total revenues $ 160,753 100.0 % $ 132,213 100.0 % $ 28,540 21.6 %


	Three Months Ended
	March 27, 2021		% of Revenues		March 28, 2020		% of Revenues		$ Change		% Change
	(Dollars in thousands)
Probe Cards Markets:
Foundry & Logic	$	113,410	60.7	%	$	105,745	65.8	%	$	7,665	7.2	%
DRAM	33,898		18.2		24,696		15.4		9,202		37.3
Flash	11,590		6.2		4,274		2.7		7,316		171.2
Systems Market:
Systems	27,738		14.9		26,038		16.1		1,700		6.5
Total revenues	$	186,636	100.0	%	$	160,753	100.0	%	$	25,883	16.1	%

The increase in Foundry & Logic product revenue for the three months ended March ~~28, 2020,~~27, 2021, compared to the three months ended March ~~30, 2019,~~28, 2020, was driven principally by increased unit sales to large semiconductor foundries and integrated device manufacturers, ~~as they~~demonstrating success in diversifying across our strategic accounts. Additionally, sales have increased ~~manufacturing~~due to the demand for components and chipsets for 5G handsets, work and study from home infrastructure spending, and adoption of ~~new chip designs on leading-edge nodes.~~advanced packaging architectures like heterogeneous integration and high-bandwidth memory (“HBM”).

The ~~decrease~~relative increase in DRAM product revenue for the three months ended March ~~28, 2020,~~27, 2021, compared to the three months ended March ~~30, 2019,~~28, 2020, was driven by a decreased ~~unit sales~~customer demand for the three months ended March 28, 2020 as a result of ~~decreased customer demand.~~the absorption of large purchases in fiscal 2019, that did not recur in the three months ended March 27, 2021.

The ~~decrease~~increase in Flash product revenue for the three months ended March ~~28, 2020,~~27, 2021, compared to the three months ended March ~~30, 2019,~~28, 2020, was driven by ~~decreased unit~~increased sales as a result of ~~decreased~~increased customer demand asfor our legacy products and increased sales resulting from the acquisition of Baldwin Park. Our revenue in this market continues to be highly variable.

The increase in Systems product revenue for the three months ended March ~~28, 2020,~~27, 2021, compared to the three months ended March ~~30, 2019,~~28, 2020, was driven by increased sales of ~~probe stations, which includes an increase in revenue from 300mm stations,~~cryogenic systems due to the acquisition of High Precision Devices, Inc. (“HPD”) and increased sales of thermal sub-systems, partially offset by lower ~~revenue from thermal sub-systems and 200mm stations.~~300mm station sales.

Due to COVID-19, there were various impacts across our segments due to governmental mandates of social distancing. This resulted in a temporary factory ~~shut down~~shutdown for almost two weeks during our first fiscal quarter of 2020 in certain locations, limiting our manufacturing capacity. ~~These~~We believe these shutdowns negatively affected revenue and impacted our ability to maintain typical lead times, especially in our Probes segment. The plant shutdowns we experienced in the first fiscal quarter of 2020 did not recur in the first fiscal quarter of 2021, which presumably drove some of the increased sales in the first fiscal quarter of 2021 over the first fiscal quarter of 2020, particularly in the Probe Cards segment where the plant shutdowns in 2020 were longer in duration than the shutdowns for the Systems segment.

Revenues by Geographic Region


		Three Months Ended															Three Months Ended
		March 28, 2020		% of Revenue		March 30, 2019		% of Revenue			March 27, 2021		% of Revenue		March 28, 2020		% of Revenue
		(Dollars in thousands)															(Dollars in thousands)
Taiwan										Taiwan	$	45,580	24.4	%	$	31,780	19.8	%
China	China	$	43,642	27.1	%	$	21,843	16.5	%	China	42,625		22.8	%	43,642		27.1	%
United States	United States	31,916		19.9	%	34,263		25.9	%	United States	29,486		15.8	%	31,916		19.9	%
Taiwan		31,780		19.8	%	22,387		16.9	%
Asia-Pacific1										Asia-Pacific1	28,958		15.5	%	7,863		4.9	%
South Korea										South Korea	19,085		10.2	%	14,088		8.8	%
Europe	Europe	21,043		13.1	%	9,493		7.2	%	Europe	9,999		5.4	%	21,043		13.1	%
South Korea		14,088		8.8	%	26,723		20.2	%
Japan	Japan	8,370		5.2	%	10,432		7.9	%	Japan	9,321		5.0	%	8,370		5.2	%
Asia-Pacific¹		7,863		4.9	%	3,263		2.5	%
Rest of the world	Rest of the world	2,051		1.2	%	3,809		2.9	%	Rest of the world	1,582		0.9	%	2,051		1.2	%
Total revenues	Total revenues	$	160,753	100.0	%	$	132,213	100.0	%	Total revenues	$	186,636	100.0	%	$	160,753	100.0	%

¹ Asia-Pacific includes all countries in the region except China, Japan, South Korea and Taiwan, which are disclosed separately.

Geographic revenue information is based on the location to which we ship the product. For example, if a certain South Korean customer purchases through their U.S. subsidiary and requests the products to be shipped to an address in South Korea, this sale will be reflected in the revenue for South Korea rather than the U.S.

Changes in revenue by geographic region for the three months ended March ~~28, 2020,~~27, 2021, compared to the three months ended March ~~30, 2019, was~~28, 2020, were primarily attributable to changes in customer demand, shifts in customer regional manufacturing strategies, particularly with our large multinational customers, and product sales mix.

Cost of Revenues and Gross Margins

Cost of revenues consists primarily of manufacturing materials, compensation and benefits, shipping and handling costs, manufacturing-related overhead and amortization of certain intangible assets. Our manufacturing operations rely on a limited number of suppliers to provide key components and materials for our products, some of which are a sole source. We order materials and supplies based on backlog and forecasted customer orders. Tooling and setup costs related to changing manufacturing lots at our suppliers are also included in the cost of revenues. We expense all warranty costs, inventory provisions and amortization of certain intangible assets as cost of revenues.

Our gross profit and gross margin were as follows (dollars in thousands):


		Three Months Ended																			Three Months Ended
		March 28, 2020			March 30, 2019			$ Change		% Change			March 27, 2021			March 28, 2020			$ Change		% Change
Gross profit	Gross profit	$	67,390		$	52,521		$	14,869	28.3	%	Gross profit	$	76,706		$	67,390		$	9,316	13.8	%
Gross margin	Gross margin	41.9		%	39.7		%					Gross margin	41.1		%	41.9		%

Our gross profit and gross margin by segment were as follows (dollars in thousands):


		Three Months Ended																																														Three Months Ended
		March 28, 2020																					March 30, 2019																						March 27, 2021						March 28, 2020
		Probe Cards			Systems			Corporate and Other			Total			Probe Cards			Systems			Corporate and Other			Total				Probe Cards			Systems			Corporate and Other			Total			Probe Cards			Systems			Corporate and Other			Total
Gross profit	Gross profit	$	60,743		$	13,334		$	(6,687)		$	67,390		$	45,294		$	13,016		$	(5,789)		$	52,521		Gross profit	$	70,315		$	13,599		$	(7,208)		$	76,706		$	60,743		$	13,334		$	(6,687)		$	67,390
Gross margin	Gross margin	45.1		%	51.2		%	—		%	41.9		%	41.9		%	54.0		%	—		%	39.7		%	Gross margin	44.3		%	49.0		%	—		%	41.1		%	45.1		%	51.2		%	—		%	41.9		%

Probe Cards

For the three months ended March ~~28, 2020,~~27, 2021, gross profit and gross margins ~~increased~~decreased compared to the three months ended March ~~30, 2019,~~28, 2020, primarily due to ~~increased~~less favorable absorption of costs from the mix of volumes through production sites and due

to product mix on a less favorable mix of higher gross margin Foundry & Logic probe card sales ~~and~~combined with higher ~~factory utilization.~~sales of lower gross margin Flash probe cards.

Systems

For the three months ended March ~~28, 2020,~~27, 2021, gross ~~profit increased while gross margin~~margins decreased compared to the three months ended March ~~30, 2019,~~28, 2020, primarily as a result of less favorable product mix, largely related to lower sales of stations and related accessories at somewhat reduced gross margins on the lower volumes, partially offset by higher gross margins on higher sales of thermal sub-systems and additional contribution from ~~our acquisition~~HPD, which was acquired in the fourth fiscal quarter of ~~FRT GmbH.~~2020.

Corporate and Other

Corporate and Other includes unallocated expenses relating to share-based compensation and amortization of intangible assets, ~~share-based compensation,~~inventory and ~~restructuring charges, net,~~fixed asset fair value adjustments due to acquisitions which are not used in evaluating the results of, or in allocating resources to, our reportable segments.

Overall

Gross profit and gross ~~margin~~margins fluctuate with revenue levels, product mix, selling prices, factory loading and material costs. For the three months ended March ~~28, 2020,~~27, 2021, compared to the three months ended March ~~30, 2019,~~28, 2020, gross profit and gross margins have ~~improved,~~decreased, primarily on ~~higher sales.~~product mix.

Cost of revenues included stock-based compensation expense as follows (in thousands):

Three Months Ended
March 28,
2020 March 30,
2019
Stock-based compensation $ 937 $ 950

Future gross margins may be adversely impacted by lower revenues, unfavorable product mix and lower factory utilization. Our gross margins may also be adversely affected if we are required to record additional inventory write-downs for estimated average selling prices that are below cost or because of a decrease in demand.


	Three Months Ended
	March 27, 2021		March 28, 2020
Stock-based compensation	$	1,335	$	937

Research and Development


		Three Months Ended																			Three Months Ended
		March 28, 2020			March 30, 2019			$ Change		% Change			March 27, 2021			March 28, 2020			$ Change		% Change
		(Dollars in thousands)																			(Dollars in thousands)
Research and development	Research and development	$	21,267		$	19,723		$	1,544	7.8	%	Research and development	$	24,046		$	21,267		$	2,779	13.1	%
% of revenues	% of revenues	13.2		%	14.9		%					% of revenues	12.9		%	13.2		%

The increase in research and development expenses in the three months ended March ~~28, 2020~~27, 2021 when compared to the corresponding period in the prior year was primarily driven by increased headcount, ~~combined with~~increased facilities costs in other general operations, higher ~~variable compensation, partially offset by a decrease in~~ project material ~~costs.~~

~~A detail of the changes is as follows (in thousands):~~


	~~Three Months Ended March 28, 2020 compared to Three Months Ended March 30, 2019~~
~~Employee compensation~~ costs,	$	~~1,649~~
~~Depreciation~~	88
~~Stock-based compensation~~	~~(80)~~
~~Project material costs~~	~~(65)~~
~~Other general operations~~	~~(48)~~
	$	~~1,544~~

~~Research and development included stock-based compensation expense as follows (in thousands):~~

Three Months Ended
March 28,
2020 March 30,
2019
Stock-based compensation $ 1,439 $ 1,519

~~Selling, General and Administrative~~

Three Months Ended
March 28,
2020 March 30,
2019 $ Change % Change
(Dollars in thousands)
Selling, general and administrative $ 27,693 $ 25,184 $ 2,509 10.0 %
% of revenues 17.2 % 19.0 %

The increase in selling, general and administrative in the three months ended March 28, 2020 when compared to the corresponding period in the prior year was primarily due to increased headcount combined with higher variable compensation, higher stock-based compensation and higher depreciation expense. These increases are primarily related to ~~the timing~~our recent acquisitions of ~~annual grants,~~Baldwin Park and ~~higher costs from acquisition of FRT GmbH, offset partially by a decrease in the amortization of intangible assets.~~HPD.

A detail of the changes is as follows (in thousands):


	Three Months Ended March ~~28, 2020~~27, 2021 compared to Three Months Ended March ~~30, 2019~~27, 2020
Employee compensation costs	$	1,436
Project material costs	304
Stock-based compensation	250
Depreciation	114
Other general operations	675
	$	2,779

Research and development included stock-based compensation expense as follows (in thousands):


	Three Months Ended
	March 27, 2021		March 28, 2020
Stock-based compensation	$	1,689	$	1,439

Selling, General and Administrative


	Three Months Ended
	March 27, 2021			March 28, 2020			$ Change		% Change
	(Dollars in thousands)
Selling, general and administrative	$	30,015		$	27,693		$	2,322	8.4	%
% of revenues	16.1		%	17.2		%

The increase in selling, general and administrative in the three months ended March 27, 2021 when compared to the corresponding period in the prior year was primarily due to an increase in headcount, higher stock-based compensation, and increase in amortization of intangibles. These increases are primarily related to the acquisitions of Baldwin Park and HPD, partially offset by decreased travel due to travel restrictions.

A detail of the changes is as follows (in thousands):

Three Months Ended March 27, 2021 compared to Three Months Ended March 27, 2020

Employee compensation

~~1,942~~ $

2,072

Stock-based compensation

806

Amortization of intangibles

~~(858)~~202

Travel related costs

(598)

Consulting fees

~~566~~ (178)

~~Stock-based compensation~~

~~421~~

General operating expenses

~~438~~18

~~2,509~~2,322

Selling, general and administrative included stock-based compensation expense as follows (in thousands):

Three Months Ended
March 28,
2020 March 30,
2019
Stock-based compensation $ 3,247 $ 2,826


	Three Months Ended
	March 27, 2021		March 28, 2020
Stock-based compensation	$	4,053	$	3,247

Interest Income and Interest Expense


		Three Months Ended										Three Months Ended
		March 28, 2020			March 30, 2019				March 27, 2021			March 28, 2020
		(Dollars in thousands)										(Dollars in thousands)
Interest Income	Interest Income	$	685		$	580		Interest Income	$	194		$	685
Weighted average balance of cash and investments	Weighted average balance of cash and investments	$	210,791		$	151,451		Weighted average balance of cash and investments	$	266,209		$	210,791
Weighted average yield on cash and investments	Weighted average yield on cash and investments	1.68		%	2.03		%	Weighted average yield on cash and investments	0.38		%	1.68		%

Interest Expense	Interest Expense	$	318		$	595		Interest Expense	$	180		$	318
Average debt outstanding	Average debt outstanding	$	42,854		$	64,835		Average debt outstanding	$	32,263		$	42,854
Weighted average interest rate on debt	Weighted average interest rate on debt	2.50		%	4.51		%	Weighted average interest rate on debt	1.62		%	2.50		%

Interest income is earned on our cash, cash equivalents, restricted cash and marketable securities. The ~~increase~~decrease in interest income for the three months ended March ~~28, 2020~~27, 2021 compared with the corresponding period of the prior year was attributable to lower investment yields due to the low interest rate environment despite higher invested ~~balances and sustained investment yields, related in part to longer duration investments.~~balances.

Interest expense primarily includes interest on our term loans, ~~partially offset by income from our interest-rate~~interest rate swap derivative contracts, ~~as well as~~and term loan issuance costs amortization charges. The decrease in interest expense for the three months ended March ~~28, 2020~~27, 2021 compared to the same period of the prior year was primarily due to lower outstanding debt balances ~~related~~due to the ~~acquisition~~pay-off of ~~Cascade Microtech in fiscal 2016 as a result of principal payments made,~~the CMI Term Loan on June 30, 2020, partially offset by ~~additional interest expense related to~~ the ~~term loan~~Building Term Loan that originated ~~to finance the acquisition of FRT GmbH~~ in the ~~fourth~~second quarter of ~~2019.~~2020. Interest expense was also lower due to lower average interest rates on the outstanding debt.

Other ~~Expense,~~Income (Expense), Net

Other ~~expense,~~income (expense), net, primarily includes the effects of foreign currency impact and various other gains and losses.

Provision for Income Taxes


		Three Months Ended										Three Months Ended
		March 28, 2020			March 30, 2019				March 27, 2021			March 28, 2020
		(In thousands, except percentages)										(In thousands, except percentages)
Provision for income taxes	Provision for income taxes	$	2,816		$	2,032		Provision for income taxes	$	3,206		$	2,816
Effective tax rate	Effective tax rate	15.1		%	27.0		%	Effective tax rate	14.0		%	15.1		%

Provision for income taxes reflects the tax provision on our operations in foreign and U.S. jurisdictions, offset by tax benefits from tax credits and the foreign-derived intangible income ~~("FDII"~~(“FDII”) deduction. We expect the FDII deduction and corresponding benefit to be available after utilizing our previous net operating loss carryforwards, resulting in a decrease in our effective tax rate for the three months ended March 28, 2020, compared to the three months ended March 30, 2019. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, changes in ASC 718 stock-based compensation expense/benefit, future expansion into areas with varying country, state, and local income tax rates, and deductibility of certain costs and expenses by jurisdiction. We have utilized our previous net operating loss carryforwards, and expect the FDII deduction and corresponding benefit to be available, resulting in a decrease from the U.S. statutory rate and included in our worldwide effective tax rate for the year ending December 25, 2021.

Liquidity and Capital Resources

Capital Resources

Our working capital was ~~$308.8~~$351.5 million at March ~~28, 2020,~~27, 2021, compared to ~~$282.5~~$332.5 million at December ~~28, 2019.~~26, 2020.

Cash and cash equivalents primarily consist of deposits held at banks and money market funds. Marketable securities primarily consist of U.S. treasuries ~~U.S. agency securities~~ and corporate bonds. We typically invest in highly-rated securities with low probabilities of default. Our investment policy requires investments to be rated single A or better, and limits the types of acceptable investments, issuer concentration and duration of the investment.

Our cash, cash equivalents and marketable securities totaled approximately ~~$239.4~~$267.7 million at March ~~28, 2020,~~27, 2021, compared to ~~$220.9~~$255.0 million at December ~~28, 2019.~~26, 2020. We believe that we will be able to satisfy our working capital requirements and scheduled term loan repayments for at least the next twelve months with the liquidity provided by our existing cash, cash

equivalents, marketable securities and cash provided by operations. To the extent necessary, we may consider entering into short and long-term debt obligations, raising cash through a stock issuance, or obtaining new financing facilities, which may not be available on terms favorable to us. Our future capital requirements may vary materially from those now planned.

The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition. As a result of the current and uncertain future impact of COVID-19, we have taken actions to preserve and improve our liquidity primarily by limiting our exposures to volatile markets and investments, as well as actively working to minimize counterparty risk.

If we are unsuccessful in maintaining or growing our revenues, maintaining or reducing our cost structure (in response to a potential reduction in demand due to an industry downturn, COVID-19, or other event), or increasing our available cash through debt or equity financings, our cash, cash equivalents and marketable securities may ~~decline in fiscal 2020.~~decline.

We utilize a variety of tax planning and financing strategies to manage our worldwide cash and deploy funds to locations where needed. As part of these strategies, we indefinitely reinvest a portion of our foreign earnings. Should we require additional capital in the United States, we may elect to repatriate indefinitely-reinvested foreign funds or raise capital in the United States.

Cash Flows

The following table sets forth our net cash flows from operating, investing and financing activities:


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			March 27, 2021		March 28, 2020
		(In thousands)							(In thousands)
Net cash provided by operating activities	Net cash provided by operating activities	$	39,339	$	20,638	Net cash provided by operating activities	$	32,356	$	39,339
Net cash used in investing activities	Net cash used in investing activities	(5,442)		(9,332)		Net cash used in investing activities	(39,922)		(5,442)
Net cash used in financing activities	Net cash used in financing activities	$	(9,071)	$	(3,932)	Net cash used in financing activities	$	(3,768)	$	(9,071)

Operating Activities

Net cash provided by operating activities for the three months ended March ~~28, 2020~~27, 2021 was primarily attributable to net income of ~~$15.9~~$19.6 million and ~~$22.7 million of~~ net non-cash expenses ~~offset~~of $27.4 million, further impacted by changes in operating assets and liabilities, as explained below.

Accounts receivable, net, decreased ~~$7.8~~$4.1 million to ~~$90.1~~$103.5 million at March ~~28, 2020,~~27, 2021, compared to ~~$97.9~~$107.6 million at December ~~28, 2019,~~26, 2020, as a result of ~~changes in customer sales mix, timing of customer shipments and timing of customer payments.~~lower revenue for the three months ended March 27, 2021, compared to the revenue for the three months ended December 26, 2020.

Inventories, net, ~~decreased $4.3~~increased $5.5 million to ~~$79.0~~$104.7 million at March ~~28, 2020,~~27, 2021, compared to ~~$83.3~~$99.2 million at December ~~28, 2019,~~26, 2020, as a result of shipping prior quarter backlog, lower inventory production, and less inventory receipts at the end of the quarter primarily due to reduced operating levels under COVID-19 restrictions, as previously described.anticipated projected customer demand.

~~Accrued liabilities decreased $7.3~~Accounts payable increased $5.7 million to ~~$29.2~~$67.7 million at March ~~28, 2020,~~27, 2021, compared to ~~$36.4~~$62.0 million at December ~~28, 2019,~~26, 2020, as a result of timing of payments ~~including~~to vendors. Accrued liabilities decreased $11.8 million to $43.5 million at March 27, 2021, compared to $55.3 million at December 26, 2020, as a result of timing of payments for accrued taxes payable, a decrease in accrued variable compensation, decrease in employee ~~performance-based~~ compensation accrual, and ~~indirect taxes.~~decrease in employee stock purchase plan accrual from the issuance of common stock to employees under our employee stock purchase plan.

Investing Activities

Net cash used in investing activities for the three months ended March ~~28, 2020~~27, 2021 was primarily related to ~~$12.1~~$13.5 million of ~~cash used in the~~ acquisition of property, plant and equipment ~~partially offset by $6.6~~and $26.5 million of net ~~proceeds from sales of~~cash used to purchase marketable securities.

Financing Activities

Net cash used in financing activities for the three months ended March ~~28, 2020~~27, 2021 primarily related to ~~$13.2~~$2.4 million of principal payments made towards the repayment of our term loans, ~~and $0.4~~$1.1 million related to tax withholding associated with the net share settlements of our equity awards, and $5.7 million used to purchase common stock under our stock repurchase program, partially offset by ~~$4.5~~$5.5 million of proceeds received from issuances of common stock under our employee stock purchase plan and stock option plans.

Debt

~~CMI Term Loan~~

On June 24, 2016, we entered into a Credit Agreement (the “Credit Agreement”) with HSBC Bank USA, National Association ("HSBC"), as administrative agent, co-lead arranger, sole bookrunner and syndication agent, other lenders that may from time-to-time be a party to the Credit Agreement, and certain guarantors. Pursuant to the Credit Agreement, the lenders have provided us with a senior secured term loan facility of $150 million (the “CMI Term Loan”). The proceeds of the CMI Term Loan were used to finance a portion of the purchase price paid in connection with the Cascade Microtech acquisition in fiscal 2016 and to pay related bank fees and expenses.

The CMI Term Loan bears interest at a rate equal to, at our option, (i) the applicable London Interbank Offered Rate ("LIBOR") rate plus 2.00% per annum or (ii) Base Rate (as defined in the Credit Agreement) plus 1.00% per annum. We have currently elected to pay interest at 2.00% over the one-month LIBOR rate. Interest payments are payable in monthly installments over a five-year period. The interest rate at March 28, 2020 was 3.61%.

The principal payments on the CMI Term Loan are paid in equal quarterly installments that began June 30, 2016, in an annual amount equal to 5% for year one, 10% for year two, 20% for year three, 30% for year four and 35% for year five. The planned final payment on the CMI Term Loan is scheduled for the third quarter of fiscal 2020.

On July 25, 2016, we entered into an interest rate swap agreement with HSBC and other lenders to hedge the interest payments on the CMI Term Loan for the notional amount of $95.6 million. As future levels of LIBOR over the life of the loan are uncertain, we entered into these interest-rate swap agreements to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreements, we convert a floating rate interest at one-month LIBOR plus 2% into a fixed rate interest at 2.939%. The interest rate swap agreement ended as of March 28, 2020.

~~The obligations under the Term Loan are guaranteed by substantially all of our assets and the assets of our domestic subsidiaries, subject to certain customary exceptions.~~

The Credit Agreement contains negative covenants customary for financing of this type, as well as certain financial maintenance covenants. As of March 28, 2020, the balance outstanding pursuant to the CMI Term Loan was $23.7 million and we were in compliance with all covenants under the Credit Agreement.

FRT Term Loan

On October 25, 2019, we entered into a $23.4 million three-year credit facility loan agreement (the ~~"FRT~~“FRT Term ~~Loan"~~Loan”) ~~with HSBC Trinkaus & Burkhardt AG, Germany,~~, to fund the acquisition of FRT GmbH, which we acquired on October 9, 2019. ~~See Note 4 for further details of the acquisition.~~

The FRT Term Loan bears interest at a rate equal to the Euro Interbank Offered Rate ~~("EURIBOR"~~(“EURIBOR”) plus ~~1.75 %~~1.75% per annum and will be repaid in quarterly installments of approximately ~~$1.9~~$2.0 million plus interest. The interest ~~beginning January 25, 2020.~~

The obligations under the FRT Term Loan are fully and unconditionally guaranteed by FormFactor, Inc. The Credit Facility contains negative covenants customary for financing of this type, including covenants that place limitations on the incurrence of additional indebtedness, the creation of liens, the payment of dividends; dispositions; fundamental changes, including mergers and acquisitions; loans and investments; sale leasebacks; negative pledges; transactions with affiliates; changes in fiscal year; sanctions and anti-bribery laws and regulations, and modifications to charter documents in a manner materially adverse to the Lenders. The FRT Term Loan also contains affirmative covenants and representations and warranties customary for financing of this type.rate at March 27, 2021 was 1.21%. As of March ~~28, 2020,~~27, 2021, the balance outstanding pursuant to the FRT term loan was ~~$21.4~~$14.4 million.

Building Term Loan

On June 22, 2020, we entered into an $18.0 million 15-year credit facility loan agreement (the “Building Term Loan”). The proceeds of the Building Term Loan were used to finance the purchase a building adjacent to our leased facilities in Livermore, California.

The Building Term Loan bears interest at a rate equal to the applicable LIBOR rate plus 1.75% per annum. Interest payments are payable in monthly installments over a fifteen-year period. The interest rate at March 27, 2021 was 1.87%. As of March 27, 2021, the balance outstanding pursuant to the Building Term Loan was $17.3 million.

On March 17, 2020, we entered into a forward starting interest rate swap agreement to hedge the interest payments on the Building Term Loan for the notional amount of $18.0 million, and an amortization period that matches the debt. As future levels of LIBOR over the life of the loan are uncertain, we ~~were~~entered into this interest-rate swap agreement to hedge the exposure in ~~compliance~~interest rate risks associated with ~~all covenants.~~movement in LIBOR rates. By entering into the agreement, we convert a floating rate interest at one-month LIBOR plus 1.75% into a fixed rate interest at 2.75%. The interest rate swap also includes a 0% floor that is effective for one year from the date of the swap. As of March 27, 2021, the notional amount of the loan that is subject to this interest rate swap is $17.3 million.

Stock Repurchase Program

In October 2020, our Board of Directors authorized a program to repurchase up to $50.0 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation plans. The share repurchase program will expire on October 28, 2022. During the three months ended March 27, 2021, we repurchased 136,402 shares of common stock for $5.7 million and, as of March 27, 2021, $44.3 million remained available for future repurchases.

Contractual Obligations and Commitments

~~Other than~~The following table summarizes our ~~operating lease~~significant contractual commitments ~~as disclosed~~to make future payments in ~~Note 12 of Notes to Condensed Consolidated Financial Statements, our~~cash under contractual obligations ~~and commitments have not materially changed~~ as of March ~~28, 2020 from those disclosed in~~27, 2021:


	Payments Due In Fiscal Year
	Remainder 2020		2021		2022		2023		2024		Thereafter		Total
Operating leases	$	6,747	$	8,040	$	6,710	$	6,297	$	7,814	$	14,416	$	50,024
Term loans - principal payments	6,949		9,276		1,050		1,080		1,111		12,258		31,724
Term loans - interest payments (1)	360		373		290		271		248		1,185		2,727
Total	$	14,056	$	17,689	$	8,050	$	7,648	$	9,173	$	27,859	$	84,475

(1) Represents our ~~Annual Report on Form 10-K~~minimum interest payment commitments at 1.87% per annum for the ~~year ended December 28, 2019.~~Building Term Loan and 1.21% per annum for the FRT Term Loan. This also excludes any amounts related to our interest rate swap.

Off-Balance Sheet Arrangements

Historically, we have not participated in transactions that have generated relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been

established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of March ~~28, 2020,~~27, 2021, we were not involved in any such off-balance sheet arrangements.

Recent Accounting Pronouncements

See Note 1,Basis of Presentation and New Accounting Pronouncements, of Notes to Condensed Consolidated Financial Statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report on Form 10-K for the fiscal year ended December ~~28, 2019.~~26, 2020. Our exposure to market risk has not changed materially since December ~~28, 2019.~~26, 2020.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) except as described below that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We implemented an enterprise resource planning (“ERP”) system in January 2021 that supports our operations and financial reporting for two of our factories located in Beaverton, Oregon and Theindorf, Germany, in a next step to unify our worldwide ERP system. This significantly impacted our business and financial transaction and reporting processes for these locations. We are taking steps to monitor and maintain appropriate internal control over financial reporting and will continue to evaluate these controls for effectiveness.

Limitations on the Effectiveness of Controls

Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

CEO and CFO Certifications

We have attached as exhibits to this Quarterly Report on Form 10-Q the certifications of our Chief Executive Officer and Chief Financial Officer, which are required in accordance with the Exchange Act. We recommend that this Item 4 be read in conjunction with the certifications for a more complete understanding of the subject matter presented.

PART II - OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes during the three months ended March ~~28, 2020~~27, 2021 to the risk factors discussed in our Annual Report on Form 10-K for the year ended December ~~28, 2019 apart from the risk factor described below.~~26, 2020. If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described

in our Annual Report on Form 10-K for the year ended December ~~28, 2019~~26, 2020 are not the only ones we face. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations.

~~The COVID-19 pandemic has impacted, and is expected to continue to negatively impact, our operations, and those of our important suppliers, business partners and customers.~~

We are exposed to risks associated with public health crises and outbreaks of contagious diseases, such as the current outbreak of a novel strain of coronavirus ("COVID-19"). To date, COVID-19 has had, and may continue to have, an adverse impact on our operations, our supply chains and our expenses, including as a result of precautionary measures that we take in response to COVID-19.

The COVID-19 pandemic has created significant volatility, uncertainty and economic disruption, which has adversely affected, and will continue to adversely affect, our business operations and may materially and adversely affect our results of operations, cash flows and financial position.

As a result of the COVID-19 pandemic, we have experienced significant business disruptions, including temporary closures of our facilities, and the facilities of our suppliers and their supply chain partners, and restrictions on our ability to travel and service our products. For example, our corporate headquarters and many of our operations, including much of our manufacturing facilities, are located in California, which has instituted health orders applicable to our operations and employees in the region. In other regions where we operate globally, similar health orders have been issued which have had, and will continue to have, similar affects upon our business. This has significantly impacted our ability to design, produce, deliver and support our products for customers. These unprecedented measures to slow the spread of COVID-19 taken by local and regional governments have had, and will continue to have, a significant negative impact on our operations.

A significant amount of our management resources has been, and will continue to be, focused on mitigating the negative impacts of COVID-19 on our business. This has required, and will continue to require, a substantial investment of time and resources across our enterprise that has delayed, or may continue to delay other valuable activities, such as the development of new technologies, products or capabilities. In addition, many of our employees are working remotely for an extended period which can increase operational risk and cybersecurity risks. If we do not respond appropriately to the COVID-19 pandemic, or if customers do not perceive our response positively, we could suffer damage to our reputation, which could adversely affect our business.

The extent to which the COVID-19 pandemic impacts us will depend on numerous evolving factors and future developments that we are not able to predict, including: the severity of the virus; the duration of the outbreak; governmental, business and other actions (which could include restrictions on our operations); the ongoing requirements of social distancing and shelter-in-place orders; the impacts on our supply chain; the impact of the pandemic on economic activity; the extent and duration of the effect on business confidence and investments by our customers; the effects of changes to our operations that may continue indefinitely; the health of and the effect on our workforce and our ability to meet our staffing needs, particularly if members of our workforce are exposed or infected; any impairments in the value of our assets which could be recorded as a result of weaker economic conditions; and the potential impacts upon our internal controls including those over financial reporting that may result from changes in working environments and other circumstances. If the pandemic continues to create disruptions in the credit and financial markets, it could also adversely affect our ability to access capital on favorable terms to meet our business and strategic objectives. All of these circumstances are highly uncertain and cannot be predicted. In addition, the circumstances which give rise to new or existing infectious diseases becoming epidemics or pandemics with potentially similar impacts are expected to persist.

We obtain some of the components and materials used in our products from a sole source or a limited group of suppliers, and in some cases alternative sources are not readily available. Our dependence upon sole or limited source suppliers increases our exposure to the impacts of COVID-19 that might disrupt the operations of one or more of these suppliers, resulting in an inability to obtain an adequate supply of materials, late deliveries or poor component quality while we seek to identify and qualify alternative suppliers.

In addition, the COVID-19 pandemic has adversely affected, and may continue to adversely affect, regional and global economies and financial markets that can result in a period of economic slowdown or recession that could curtail or delay spending by businesses and consumers which may ultimately result in reductions in the demand for our products. As a result of the uncertain scope and duration of the COVID-19 pandemic and the uncertain timing of the regional and global recovery and economic normalization, we are unable to estimate the impacts on our operations and financial results. As a result, we may decide to limit or refrain from providing financial guidance in the manner we have done for recent reporting periods. All of these factors may negatively affect our stock price.

Item 2.

~~Increasingly restrictive export regulations~~ Unregistered Sales of Equity Securities and ~~other trade barriers may materially harm our business.~~Use of Proceeds

~~Sales~~Repurchase of our products to customers outside of the United States represent a significant part of our past and anticipated revenues, including sales involving exports from the United States to China. In 2019, sales in China represented 18% of our revenues, and China is an area of potential growth for our business. We have observed a continuing trend of increasing tariffs and trade controls affecting exports to China. For example, the U.S. Department of Commerce, Bureau of Industry and Security, has recently published amendments to the U.S. Export Administration Regulations to expand license requirements on exports to entities in China that may support military end uses. These rules are expected to, among other things, expand export license requirements on a broader set of items from the U.S., including many of our products. There is no assurance that we will obtain any such licenses on a timely basis or at all. There also remains considerable uncertainty regarding the interpretation and implementation of these rules. These and other regulatory changes could materially and negatively affect our future sales and operating results.

Common Stock

The following table summarizes our repurchases of outstanding common stock for the three months ended March 27, 2021:


Period (fiscal months)	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)	Maximum Amount that May Yet Be Purchased Under the Plans or Programs
December 27, 2020 - January 23, 2021	—	$	—	—	$	50,000,000
January 24, 2021 - February 20, 2021	—	$	—	—	$	50,000,000
February 21, 2021 - March 27, 2021	136,402	$	42.07	136,402	$	44,261,568
	136,402	42.07		136,402

1 In October 2020, our Board of Directors authorized a program to repurchase up to $50.0 million of outstanding common stock to offset potential dilution from issuances of our common stock under our employee stock purchase plan and equity incentive plan. Under the authorized stock repurchase program, we may repurchase shares from time to time on the open market. The pace of repurchase activity will depend on levels of cash generation, current stock price and other factors. The program may be modified or discontinued at any time. The share repurchase program will expire on October 28, 2022.

Item 6. Exhibits

The following exhibits are filed herewith and this list constitutes the exhibit index.

Exhibit

Incorporated by Reference

Filed

Exhibit

Incorporated by Reference

Filed

Number

Exhibit Description

Form

Date

Number

Herewith

Number

Exhibit Description

Form

Date

Number

Herewith

3.1

Amended and Restated Certificate of Incorporation of the Registrant as filed with the Delaware Secretary of State on June 17, 2003

S-1

October 20, 2003

3.01

3.1

Amended and Restated Certificate of Incorporation of the Registrant as filed with the Delaware Secretary of State on June 17, 2003

S-1

October 20, 2003

3.01

3.2

Amended and Restated Bylaws of the Registrant

8-K

July 22, 2016

3.2

Amended and Restated Bylaws of the Registrant

8-K

July 22, 2016

3.2

31.01

Certification of Chief Executive Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.01

Certification of Chief Executive Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.02

Certification of Chief Financial Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.02

Certification of Chief Financial Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.01

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.01

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101

The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2021, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags

101.INS

XBRL Instance Document

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

104

The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2021, formatted in Inline XBRL (included as Exhibit 101)

______________________________________

* This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

3235

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

FormFactor, Inc.

Date:

May ~~7, 2020~~4, 2021

By:

/s/ SHAI SHAHAR

Shai Shahar

Chief Financial Officer

(Duly Authorized Officer, Principal Financial Officer, and Principal Accounting Officer)

3336


	Units	Weighted Average Grant Date Fair Value
RSUs at December 28, 2019	3,069,000	$	14.30
Awards granted	16,000	26.05
Awards vested	(43,604)	12.70
Awards forfeited	(20,291)	14.25
RSUs at March 28, 2020	3,021,105	$	14.39